The	O
functional	O
synergy	O
between	O
IL-12	B-protein
and	O
IL-2	B-protein
involves	O
p38	B-protein
mitogen-activated	I-protein
protein	I-protein
kinase	I-protein
and	O
is	O
associated	O
with	O
the	O
augmentation	O
of	O
STAT	O
serine	O
phosphorylation	O
.	O

IL-12	B-protein
and	O
IL-2	B-protein
can	O
stimulate	O
mitogen-	B-cell_type
or	I-cell_type
CD3-activated	I-cell_type
T	I-cell_type
cells	I-cell_type
to	O
proliferate	O
,	O
produce	O
IFN-gamma	B-protein
,	O
and	O
kill	O
tumor	B-cell_type
cells	I-cell_type
.	O

The	O
magnitude	O
of	O
these	O
functional	O
responses	O
is	O
greatly	O
augmented	O
when	O
T	B-cell_type
cells	I-cell_type
are	O
activated	O
by	O
the	O
combination	O
of	O
IL-12	B-protein
and	O
IL-2	B-protein
.	O

Although	O
peripheral	O
blood	O
T	B-cell_type
cells	I-cell_type
are	O
largely	O
unresponsive	O
to	O
these	O
cytokines	B-protein
without	O
prior	O
activation	O
,	O
a	O
small	O
subset	O
of	O
CD8+	B-cell_type
T	I-cell_type
cells	I-cell_type
(	O
CD8+CD18bright	B-cell_type
)	O
is	O
strongly	O
activated	O
by	O
the	O
combination	O
of	O
IL-12	B-protein
and	O
IL-2	B-protein
.	O

In	O
this	O
report	O
we	O
show	O
that	O
the	O
functional	O
synergy	O
between	O
IL-12	B-protein
and	O
IL-2	B-protein
in	O
CD8+CD18bright	B-cell_type
T	I-cell_type
cells	I-cell_type
correlates	O
with	O
the	O
activation	O
of	O
the	O
stress	B-protein
kinases	I-protein
,	O
p38	B-protein
mitogen-activated	I-protein
protein	I-protein
(	I-protein
MAP	I-protein
)	I-protein
kinase	I-protein
and	O
stress-activated	B-protein
protein	I-protein
kinase	I-protein
(	I-protein
SAPK	I-protein
)	I-protein
/Jun	I-protein
N-terminal	I-protein
kinase	I-protein
,	O
but	O
not	O
with	O
the	O
activation	O
of	O
the	O
extracellular	B-protein
signal-regulated	I-protein
kinases	I-protein
.	O

The	O
functional	O
synergy	O
between	O
IL-2	B-protein
and	O
IL-12	B-protein
is	O
also	O
associated	O
with	O
a	O
prominent	O
increase	O
in	O
STAT1	B-protein
and	O
STAT3	B-protein
serine	O
phosphorylation	O
over	O
that	O
observed	O
with	O
IL-12	B-protein
or	O
IL-2	B-protein
alone	O
.	O

By	O
contrast	O
,	O
STAT	B-protein
tyrosine	O
phosphorylation	O
is	O
not	O
augmented	O
over	O
that	O
seen	O
with	O
either	O
cytokine	O
alone	O
.	O

A	O
specific	O
inhibitor	O
of	O
p38	O
MAP	O
kinase	O
completely	O
inhibits	O
the	O
serine	O
phosphorylation	O
of	O
STAT1	B-protein
and	O
STAT3	B-protein
induced	O
by	O
IL-12	B-protein
and	O
IL-2	B-protein
and	O
abrogates	O
the	O
functional	O
synergy	O
between	O
IL-12	B-protein
and	O
IL-2	B-protein
without	O
affecting	O
STAT	O
tyrosine	O
phosphorylation	O
.	O

This	O
suggests	O
that	O
p38	O
MAP	O
kinase	O
may	O
play	O
an	O
important	O
role	O
in	O
regulating	O
STAT	O
serine	O
phosphorylation	O
in	O
response	O
to	O
the	O
combination	O
of	O
IL-12	B-protein
and	O
IL-2	B-protein
.	O

Furthermore	O
,	O
these	O
findings	O
indicate	O
that	O
the	O
optimal	O
activation	O
of	O
T	B-cell_type
cells	I-cell_type
by	O
IL-12	B-protein
and	O
IL-2	B-protein
may	O
depend	O
on	O
an	O
interaction	O
between	O
the	O
p38	B-protein
MAP	I-protein
kinase	I-protein
and	O
Janus	B-protein
kinase/STAT	I-protein
signaling	O
pathways	O
.	O

Le	NULL
~	NULL
.	NULL

__	NULL
The	NULL
Attune	NULL
``	NULL
NXT	NULL
Flow	NULL
Cytometer	NULL
system	NULL
_-	NULL
_-	NULL
Let	NULL
's	NULL
get	NULL
to	NULL
the	NULL
science	NULL
invitrogen	NULL
The	NULL
Functional	NULL
Synergy	NULL
Between	NULL
IL-12	NULL
and	NULL
Pn	NULL
1	NULL
,	NULL
Aﬁxlﬁiﬂlﬁ	NULL
‘	NULL
ﬁzélo	NULL
gy	NULL
IL-2	NULL
Involves	NULL
p38	NULL
Mitogen-Activated	NULL
Protein	NULL
Kinase	NULL
and	NULL
Is	NULL
Associated	NULL
with	NULL
the	NULL
Augmentation	NULL
of	NULL
STAT	NULL
Serine	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
Phosphorylation	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Jared	NULL
A.	NULL
Gollob	NULL
,	NULL
Claudia	NULL
P.	NULL
Schnipper	NULL
,	NULL
Erin	NULL
A.	NULL
Murphy	NULL
,	NULL
Jerome	NULL
Ritz	NULL
and	NULL
David	NULL
A.	NULL
Frank	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:4472-4481	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/8/4472	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
49	NULL
articles	NULL
,	NULL
32	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/8/4472	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Functional	NULL
Synergy	NULL
Between	NULL
IL-12	NULL
and	NULL
IL-2	NULL
Involves	NULL
p38	NULL
Mitogen-Activated	NULL
Protein	NULL
Kinase	NULL
and	NULL
Is	NULL
Associated	NULL
with	NULL
the	NULL
Augmentation	NULL
of	NULL
STAT	NULL
Serine	NULL
Phosphorylation	NULL
Jared	NULL
A.	NULL
Gollob	NULL
,	NULL
``	NULL
Claudia	NULL
P.	NULL
Schnipper	NULL
,	NULL
Erin	NULL
A.	NULL
Murphy	NULL
,	NULL
Jerome	NULL
Ritz	NULL
,	NULL
and	NULL
David	NULL
A.	NULL
Frank	NULL
IL-12	NULL
and	NULL
IL-2	NULL
can	NULL
stimulate	NULL
mitogen-	NULL
or	NULL
CD3-activated	NULL
T	NULL
cells	NULL
to	NULL
proliferate	NULL
,	NULL
produce	NULL
IFN-y	NULL
,	NULL
and	NULL
kill	NULL
tumor	NULL
cells	NULL
.	NULL

The	NULL
magnitude	NULL
of	NULL
these	NULL
functional	NULL
responses	NULL
is	NULL
greatly	NULL
augmented	NULL
when	NULL
T	NULL
cells	NULL
are	NULL
activated	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

Although	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
are	NULL
largely	NULL
unresponsive	NULL
to	NULL
these	NULL
cytokines	NULL
without	NULL
prior	NULL
activation	NULL
,	NULL
a	NULL
small	NULL
subset	NULL
of	NULL
CD8*	NULL
T	NULL
cells	NULL
(	NULL
CDS*	NULL
CD18®	NULL
``	NULL
*	NULL
)	NULL
is	NULL
strongly	NULL
activated	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
show	NULL
that	NULL
the	NULL
functional	NULL
synergy	NULL
between	NULL
IL-12	NULL
and	NULL
IL-2	NULL
in	NULL
CD8¢	NULL
CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
correlates	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
stress	NULL
kinases	NULL
,	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinase	NULL
and	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
(	NULL
SAPK	NULL
)	NULL
/Jun	NULL
N-terminal	NULL
kinase	NULL
,	NULL
but	NULL
not	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
extracellular	NULL
signal-regulated	NULL
kinases	NULL
.	NULL

The	NULL
functional	NULL
synergy	NULL
between	NULL
IL-2	NULL
and	NULL
IL-12	NULL
is	NULL
also	NULL
associated	NULL
with	NULL
a	NULL
prominent	NULL
increase	NULL
in	NULL
STAT1	NULL
and	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
over	NULL
that	NULL
observed	NULL
with	NULL
IL-12	NULL
or	NULL
IL-2	NULL
alone	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
STAT	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
not	NULL
augmented	NULL
over	NULL
that	NULL
seen	NULL
with	NULL
either	NULL
cytokine	NULL
alone	NULL
.	NULL

A	NULL
specific	NULL
inhibitor	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
completely	NULL
inhibits	NULL
the	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
induced	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
and	NULL
abrogates	NULL
the	NULL
functional	NULL
synergy	NULL
between	NULL
IL-12	NULL
and	NULL
IL-2	NULL
without	NULL
affecting	NULL
STAT	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
p38	NULL
MAP	NULL
kinase	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulating	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

Furthermore	NULL
,	NULL
these	NULL
findings	NULL
indicate	NULL
that	NULL
the	NULL
optimal	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
may	NULL
depend	NULL
on	NULL
an	NULL
interaction	NULL
between	NULL
the	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
Janus	NULL
kinase/STAT	NULL
signaling	NULL
pathways	NULL
.	NULL

effects	NULL
on	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

To	NULL
respond	NULL
to	NULL
either	NULL
IL-12	NULL
or	NULL
IL-2	NULL
,	NULL
T	NULL
cells	NULL
must	NULL
first	NULL
be	NULL
activated	NULL
with	NULL
a	NULL
mitogen	NULL
such	NULL
as	NULL
PHA	NULL
or	NULL
through	NULL
ligation	NULL
of	NULL
the	NULL
TCR/CD3	NULL
complex	NULL
(	NULL
1	NULL
)	NULL
.	NULL

One	NULL
of	NULL
the	NULL
primary	NULL
mechanisms	NULL
through	NULL
which	NULL
T	NULL
cell	NULL
activation	NULL
confers	NULL
responsiveness	NULL
to	NULL
IL-12	NULL
or	NULL
IL-2	NULL
is	NULL
through	NULL
the	NULL
up-regulation	NULL
of	NULL
the	NULL
receptor	NULL
subunits	NULL
for	NULL
these	NULL
cytokines	NULL
(	NULL
2-5	NULL
)	NULL
.	NULL

Although	NULL
both	NULL
cytokines	NULL
stimulate	NULL
cytolytic	NULL
activity	NULL
(	NULL
6	NULL
)	NULL
,	NULL
proliferation	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
,	NULL
and	NULL
IFN-y	NULL
production	NULL
(	NULL
9	NULL
)	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
magnitudes	NULL
of	NULL
these	NULL
functional	NULL
effects	NULL
elicited	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
are	NULL
different	NULL
.	NULL

For	NULL
ex-ample	NULL
,	NULL
while	NULL
IL-2	NULL
is	NULL
the	NULL
more	NULL
potent	NULL
stimulator	NULL
of	NULL
proliferation	NULL
and	NULL
cytolytic	NULL
activity	NULL
(	NULL
7	NULL
,	NULL
10	NULL
,	NULL
11	NULL
)	NULL
,	NULL
IL-12	NULL
is	NULL
a	NULL
stronger	NULL
inducer	NULL
of	NULL
IFN-y	NULL
production	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
IL-12	NULL
differs	NULL
from	NULL
IL-2	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
promote	NULL
the	NULL
differentiation	NULL
of	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
into	NULL
Th1	NULL
cells	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

The	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
IL-12	NULL
and	NULL
IL-2	NULL
together	NULL
has	NULL
an	NULL
additive	NULL
effect	NULL
on	NULL
cytolytic	NULL
activity	NULL
and	NULL
a	NULL
synergistic	NULL
effect	NULL
on	NULL
proliferation	NULL
and	NULL
IFN-y	NULL
production	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

While	NULL
resting	NULL
T	NULL
cells	NULL
are	NULL
largely	NULL
unresponsive	NULL
to	NULL
IL-12	NULL
or	NULL
IL-2	NULL
,	NULL
a	NULL
small	NULL
number	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
appear	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
producing	NULL
IFN-y	NULL
when	NULL
stimulated	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
(	NULL
9	NULL
)	NULL
.	NULL

I	NULL
nterleukin-12	NULL
and	NULL
IL-2	NULL
have	NULL
both	NULL
overlapping	NULL
and	NULL
distinct	NULL
Department	NULL
of	NULL
Adult	NULL
Oncology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
Received	NULL
for	NULL
publication	NULL
September	NULL
17	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
January	NULL
22	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
CA41619	NULL
,	NULL
American	NULL
Cancer	NULL
Society	NULL
Grant	NULL
PRTA-33	NULL
,	NULL
the	NULL
Barbara	NULL
and	NULL
Morris	NULL
Lidman	NULL
Research	NULL
Foundation	NULL
,	NULL
the	NULL
Kurz	NULL
Family	NULL
Foundation	NULL
,	NULL
and	NULL
the	NULL
Thomas	NULL
H.	NULL
Cosgrove	NULL
family	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Jared	NULL
A.	NULL
Gollob	NULL
,	NULL
Beth	NULL
Israel	NULL
Deaconess	NULL
Medical	NULL
Center	NULL
,	NULL
Division	NULL
of	NULL
Hematology/Oncology	NULL
,	NULL
330	NULL
Brookline	NULL
Ave.	NULL
,	NULL
East	NULL
Campus	NULL
,	NULL
Kirstein	NULL
Hall	NULL
1	NULL
,	NULL
Room	NULL
KS	NULL
158	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02215	NULL
.	NULL

E-mail	NULL
:	NULL
jgollob	NULL
@	NULL
bidmc.harvard.edu	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
;	NULL
4472-4481	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
on	NULL
T	NULL
cell	NULL
function	NULL
reflect	NULL
the	NULL
similarities	NULL
and	NULL
differences	NULL
in	NULL
the	NULL
signaling	NULL
pathways	NULL
that	NULL
are	NULL
activated	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
these	NULL
cytokines	NULL
.	NULL

Among	NULL
the	NULL
MAP	NULL
``	NULL
kinases	NULL
,	NULL
IL-2	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
extracellular	NULL
signal-regulated	NULL
ki-nase-1	NULL
(	NULL
ERK1	NULL
)	NULL
and	NULL
ERK2	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
as	NULL
well	NULL
as	NULL
p38	NULL
MAP	NULL
kinase	NULL
in	NULL
a	NULL
murine	NULL
T	NULL
cell	NULL
line	NULL
(	NULL
16	NULL
)	NULL
,	NULL
while	NULL
IL-12	NULL
can	NULL
activate	NULL
ERK	NULL
1	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
ERK	NULL
or	NULL
p38	NULL
MAP	NULL
kinase	NULL
activation	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
IL-2-	NULL
or	NULL
IL-12-mediated	NULL
cytolytic	NULL
activity	NULL
or	NULL
IFN-y	NULL
production	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

One	NULL
report	NULL
has	NULL
suggested	NULL
that	NULL
ERK2	NULL
activation	NULL
is	NULL
necessary	NULL
but	NULL
not	NULL
sufficient	NULL
for	NULL
IL-2-induced	NULL
T	NULL
cell	NULL
proliferation	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Several	NULL
other	NULL
studies	NULL
have	NULL
implicated	NULL
p38	NULL
MAP	NULL
kinase	NULL
in	NULL
the	NULL
proliferative	NULL
response	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
IL-2	NULL
and	NULL
IL-7	NULL
(	NULL
16	NULL
)	NULL
and	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IL-6	NULL
production	NULL
by	NULL
TNF-a	NULL
(	NULL
18	NULL
)	NULL
.	NULL

IL-12	NULL
and	NULL
IL-2	NULL
also	NULL
activate	NULL
both	NULL
distinct	NULL
and	NULL
overlapping	NULL
components	NULL
of	NULL
the	NULL
JAK/STAT	NULL
signaling	NULL
pathway	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Whereas	NULL
IL-12	NULL
activates	NULL
JAK2	NULL
and	NULL
Tyk2	NULL
,	NULL
IL-2	NULL
activates	NULL
JAK	NULL
1	NULL
and	NULL
JAK3	NULL
(	NULL
19	NULL
)	NULL
.	NULL

STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STATS	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
are	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
,	NULL
while	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
STAT4	NULL
,	NULL
and	NULL
STATS	NULL
can	NULL
all	NULL
be	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
20	NULL
,	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

The	NULL
important	NULL
role	NULL
of	NULL
JAK/STAT	NULL
signaling	NULL
in	NULL
mediating	NULL
the	NULL
functional	NULL
effects	NULL
of	NULL
IL-12	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
the	NULL
phenotype	NULL
of	NULL
STAT4	NULL
knockout	NULL
mice	NULL
(	NULL
24	NULL
)	NULL
.	NULL

In	NULL
mice	NULL
lacking	NULL
STAT4	NULL
,	NULL
all	NULL
the	NULL
major	NULL
functional	NULL
effects	NULL
of	NULL
IL-12	NULL
on	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
are	NULL
markedly	NULL
inhib-ited	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
JAK/STAT	NULL
signaling	NULL
in	NULL
lymphocyte	NULL
IL-2	NULL
responsiveness	NULL
has	NULL
been	NULL
shown	NULL
by	NULL
the	NULL
diminished	NULL
functional	NULL
response	NULL
to	NULL
IL-2	NULL
in	NULL
JAK3	NULL
and	NULL
STATS5	NULL
knockout	NULL
mice	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
cytokines	NULL
can	NULL
induce	NULL
the	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
MAP	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
;	NULL
JAK	NULL
,	NULL
Janus	NULL
kinase	NULL
;	NULL
PE	NULL
,	NULL
phycoerythrin	NULL
;	NULL
ATF-2	NULL
,	NULL
activating	NULL
transcription	NULL
factor-2	NULL
;	NULL
ERK	NULL
,	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
;	NULL
SAPK	NULL
,	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STATs	NULL
as	NULL
well	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
's	NULL
is	NULL
required	NULL
for	NULL
dimerization	NULL
,	NULL
nuclear	NULL
translocation	NULL
,	NULL
and	NULL
DNA	NULL
binding	NULL
and	NULL
is	NULL
therefore	NULL
necessary	NULL
to	NULL
induce	NULL
STAT-responsive	NULL
gene	NULL
transcription	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
may	NULL
be	NULL
an	NULL
important	NULL
modulator	NULL
of	NULL
both	NULL
STAT	NULL
DNA	NULL
binding	NULL
and	NULL
STAT-mediated	NULL
transcriptional	NULL
activity	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
relative	NULL
importance	NULL
of	NULL
STAT	NULL
tyrosine	NULL
phosphorylation	NULL
vs	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
in	NULL
the	NULL
functional	NULL
response	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
cytokines	NULL
remains	NULL
undefined	NULL
.	NULL

Several	NULL
cytokines	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
in	NULL
addition	NULL
to	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

IL-2	NULL
can	NULL
induce	NULL
the	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STATS	NULL
(	NULL
29	NULL
)	NULL
,	NULL
whereas	NULL
IL-6	NULL
(	NULL
30	NULL
)	NULL
and	NULL
IFN-y	NULL
(	NULL
27	NULL
)	NULL
can	NULL
stimulate	NULL
STAT3	NULL
and	NULL
STAT1	NULL
serine	NULL
phosphorylation	NULL
,	NULL
respectively	NULL
.	NULL

Both	NULL
IL-12	NULL
and	NULL
IFN-a	NULL
stimulate	NULL
STAT4	NULL
serine	NULL
phosphorylation	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
's	NULL
induced	NULL
by	NULL
IL-12	NULL
or	NULL
IL-2	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
Janus	NULL
family	NULL
kinases	NULL
that	NULL
associate	NULL
with	NULL
IL-12	NULL
or	NULL
IL-2	NULL
receptor	NULL
subunits	NULL
and	NULL
are	NULL
activated	NULL
following	NULL
receptor	NULL
ligation	NULL
.	NULL

However	NULL
,	NULL
the	NULL
serine/threonine	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
responsible	NULL
for	NULL
cytokine-induced	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
in	NULL
lymphocytes	NULL
has	NULL
not	NULL
been	NULL
identified	NULL
.	NULL

While	NULL
epidermal	NULL
growth	NULL
factor-in-duced	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
in	NULL
a	NULL
fibroblast	NULL
cell	NULL
line	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
ERK	NULL
(	NULL
30	NULL
)	NULL
,	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
by	NULL
IL-6	NULL
in	NULL
HepG2	NULL
cells	NULL
(	NULL
30	NULL
)	NULL
and	NULL
STATS	NULL
serine	NULL
phosphorylation	NULL
by	NULL
IL-2	NULL
in	NULL
a	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
(	NULL
29	NULL
)	NULL
were	NULL
both	NULL
found	NULL
to	NULL
occur	NULL
independently	NULL
of	NULL
ERK	NULL
activation	NULL
.	NULL

In	NULL
human	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
cells	NULL
,	NULL
the	NULL
constitutive	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
was	NULL
found	NULL
to	NULL
also	NULL
occur	NULL
independently	NULL
of	NULL
ERK	NULL
activation	NULL
(	NULL
32	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
other	NULL
serine/threonine	NULL
kinases	NULL
such	NULL
as	NULL
p38	NULL
MAP	NULL
kinase	NULL
or	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
(	NULL
SAPK	NULL
)	NULL
/JNK	NULL
may	NULL
be	NULL
capable	NULL
of	NULL
mediating	NULL
cytokine-induced	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Although	NULL
the	NULL
JAK/STAT	NULL
and	NULL
MAP	NULL
kinase	NULL
family	NULL
signaling	NULL
pathways	NULL
appear	NULL
to	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
the	NULL
functional	NULL
response	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
IL-2	NULL
and	NULL
IL-12	NULL
,	NULL
very	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
signaling	NULL
mechanism	NULL
that	NULL
underlies	NULL
the	NULL
functional	NULL
synergy	NULL
observed	NULL
between	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

One	NULL
report	NULL
found	NULL
that	NULL
IFN-y	NULL
mRNA	NULL
transcripts	NULL
were	NULL
stabilized	NULL
in	NULL
lymphocytes	NULL
stimulated	NULL
with	NULL
IL-12	NULL
and	NULL
IL-2	NULL
(	NULL
33	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
might	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
synergistic	NULL
increase	NULL
in	NULL
IFN-y	NULL
production	NULL
.	NULL

Although	NULL
there	NULL
is	NULL
evidence	NULL
that	NULL
the	NULL
functional	NULL
synergy	NULL
between	NULL
IL-12	NULL
and	NULL
IFN-y-inducing	NULL
factor	NULL
(	NULL
IL-18	NULL
)	NULL
is	NULL
partly	NULL
mediated	NULL
through	NULL
the	NULL
IL-12-induced	NULL
up-regulation	NULL
of	NULL
IL-18R	NULL
(	NULL
34	NULL
)	NULL
,	NULL
the	NULL
synergy	NULL
between	NULL
IL-12	NULL
and	NULL
IL-2	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
mediated	NULL
at	NULL
the	NULL
level	NULL
of	NULL
cytokine	NULL
receptor	NULL
expression	NULL
.	NULL

We	NULL
wanted	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
synergistic	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
was	NULL
mediated	NULL
through	NULL
the	NULL
modulation	NULL
of	NULL
JAK/STAT	NULL
and/or	NULL
MAP	NULL
kinase	NULL
family	NULL
signaling	NULL
.	NULL

By	NULL
examining	NULL
the	NULL
activation	NULL
of	NULL
these	NULL
signaling	NULL
pathways	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
that	NULL
respond	NULL
poorly	NULL
to	NULL
IL-12	NULL
or	NULL
IL-2	NULL
alone	NULL
but	NULL
demonstrate	NULL
strong	NULL
functional	NULL
responsiveness	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
functional	NULL
synergy	NULL
between	NULL
IL-12	NULL
and	NULL
IL-2	NULL
is	NULL
dependent	NULL
upon	NULL
the	NULL
activation	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
functional	NULL
synergy	NULL
correlates	NULL
with	NULL
the	NULL
augmentation	NULL
of	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
and	NULL
provide	NULL
evidence	NULL
that	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
induced	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
p38	NULL
MAP	NULL
kinase	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Abs	NULL
and	NULL
cytokines	NULL
The	NULL
following	NULL
unconjugated	NULL
and	NULL
PE-	NULL
or	NULL
FITC-conjugated	NULL
Abs	NULL
were	NULL
obtained	NULL
from	NULL
Coulter	NULL
(	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
:	NULL
negative	NULL
control	NULL
,	NULL
anti-CD4	NULL
,	NULL
anti-CD8	NULL
,	NULL
anti-CD56	NULL
(	NULL
NKH1	NULL
)	NULL
,	NULL
and	NULL
anti-€CD20	NULL
(	NULL
B1	NULL
)	NULL
.	NULL

Anti-CD18	NULL
(	NULL
8C12	NULL
,	NULL
IgM	NULL
)	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
7	NULL
)	NULL
and	NULL
does	NULL
not	NULL
activate	NULL
resting	NULL
or	NULL
PHA-stim-ulated	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
does	NULL
not	NULL
augment	NULL
the	NULL
response	NULL
of	NULL
resting	NULL
or	NULL
PHA-activated	NULL
T	NULL
cells	NULL
to	NULL
IL-12	NULL
or	NULL
IL-2	NULL
.	NULL

8C12	NULL
was	NULL
used	NULL
as	NULL
a	NULL
1/400	NULL
dilution	NULL
4473	NULL
of	NULL
mouse	NULL
ascites	NULL
.	NULL

FITC-conjugated	NULL
goat	NULL
anti-mouse	NULL
IgM	NULL
was	NULL
purchased	NULL
from	NULL
Southern	NULL
Biotechnology	NULL
Associates	NULL
(	NULL
Birmingham	NULL
,	NULL
AL	NULL
)	NULL
.	NULL

Unconjugated	NULL
anti-CD4	NULL
(	NULL
19thy1	NULL
)	NULL
and	NULL
anti-CD56	NULL
(	NULL
N901	NULL
)	NULL
Abs	NULL
were	NULL
used	NULL
as	NULL
dilutions	NULL
of	NULL
mouse	NULL
ascites	NULL
.	NULL

The	NULL
phospho-STAT1	NULL
Ab	NULL
recognizes	NULL
the	NULL
tyrosine	NULL
701-phosphorylated	NULL
forms	NULL
of	NULL
STAT1a	NULL
and	NULL
STAT1RB	NULL
and	NULL
cross-reacts	NULL
with	NULL
the	NULL
tyrosine	NULL
694-phosphorylated	NULL
form	NULL
of	NULL
STATS	NULL
(	NULL
20	NULL
,	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
phospho-STAT3	NULL
Ab	NULL
recognizes	NULL
the	NULL
tyrosine	NULL
705-phosphorylated	NULL
form	NULL
of	NULL
STAT3	NULL
.	NULL

The	NULL
phosphoserine-STAT1	NULL
and	NULL
phosphoserine-STAT3	NULL
Abs	NULL
specifically	NULL
recognize	NULL
the	NULL
serine	NULL
727-phosphorylated	NULL
forms	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
,	NULL
respectively	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Anti-phospho-p38	NULL
MAP	NULL
kinase	NULL
,	NULL
anti-p38	NULL
MAP	NULL
kinase	NULL
,	NULL
anti-phospho-	NULL
SAPK/	NULL
JNK	NULL
,	NULL
anti-SAPK/JNK	NULL
,	NULL
anti-phospho-ERK1/ERK2	NULL
,	NULL
anti-ERK1/ERK2	NULL
,	NULL
anti-phospho-	NULL
MKK3/MKK6	NULL
,	NULL
and	NULL
anti-phospho-ATF-2	NULL
were	NULL
all	NULL
purchased	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
(	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Horseradish	NULL
peroxidase-conjugated	NULL
rabbit	NULL
anti-mouse	NULL
and	NULL
goat	NULL
anti-rabbit	NULL
Abs	NULL
were	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
anti-phosphotyrosine	NULL
Ab	NULL
(	NULL
4G10	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Thomas	NULL
Roberts	NULL
(	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

The	NULL
Abs	NULL
to	NULL
STAT1	NULL
and	NULL
STAT3	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Recombinant	NULL
human	NULL
IL-12	NULL
(	NULL
sp	NULL
.	NULL

act	NULL
.	NULL

,	NULL
1.7	NULL
X	NULL
10	NULL
``	NULL
U/mg	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
Steven	NULL
Herrmann	NULL
at	NULL
Genetics	NULL
Institute	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

IL-2	NULL
(	NULL
sp	NULL
.	NULL

act	NULL
.	NULL

,	NULL
3.9	NULL
X	NULL
10°	NULL
U/ml	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
Amgen	NULL
(	NULL
Thousand	NULL
Oaks	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
p38	NULL
MAP	NULL
kinase	NULL
inhibitor	NULL
(	NULL
SB203580	NULL
)	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
and	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
John	NULL
C.	NULL
Lee	NULL
(	NULL
SmithKline	NULL
Beecham	NULL
Pharmaceuticals	NULL
,	NULL
King	NULL
of	NULL
Prussia	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

SB203580	NULL
was	NULL
dissolved	NULL
in	NULL
DMSO	NULL
(	NULL
Tera	NULL
Pharmaceuticals	NULL
,	NULL
Buena	NULL
Park	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
mM	NULL
and	NULL
stored	NULL
at	NULL
-20°C	NULL
.	NULL

The	NULL
MEK	NULL
inhibitor	NULL
PD98059	NULL
was	NULL
purchased	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
.	NULL

Isolation	NULL
of	NULL
PBMC	NULL
and	NULL
T	NULL
cell	NULL
subsets	NULL
Blood	NULL
samples	NULL
enriched	NULL
for	NULL
white	NULL
blood	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
normal	NULL
volunteer	NULL
donors	NULL
undergoing	NULL
platelet	NULL
pheresis	NULL
in	NULL
the	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
Blood	NULL
Bank	NULL
.	NULL

PBMC	NULL
were	NULL
isolated	NULL
from	NULL
blood	NULL
samples	NULL
through	NULL
density	NULL
gradient	NULL
centrifugation	NULL
using	NULL
Ficoll-Hypaque	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

For	NULL
the	NULL
isolation	NULL
of	NULL
CD18®	NULL
``	NULL
®	NULL
``	NULL
*	NULL
and	NULL
CD18	NULL
``	NULL
T	NULL
cells	NULL
subsets	NULL
,	NULL
PBMC	NULL
were	NULL
first	NULL
depleted	NULL
of	NULL
monocytes	NULL
through	NULL
passage	NULL
over	NULL
a	NULL
nylon	NULL
wool	NULL
col-umn	NULL
.	NULL

For	NULL
the	NULL
preparation	NULL
of	NULL
CD	NULL
#	NULL
-enriched	NULL
T	NULL
cells	NULL
,	NULL
monocyte-depleted	NULL
PBMC	NULL
were	NULL
depleted	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
NK	NULL
cells	NULL
using	NULL
Abs	NULL
to	NULL
lineage-specific	NULL
markers	NULL
(	NULL
anti-CD4	NULL
,	NULL
anti-CD20	NULL
,	NULL
and	NULL
anti-CD56	NULL
)	NULL
and	NULL
magnetic	NULL
beads	NULL
coated	NULL
with	NULL
anti-mouse	NULL
Ig	NULL
Abs	NULL
(	NULL
Advanced	NULL
Magnetics	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

CD	NULL
#	NULL
8-enriched	NULL
T	NULL
cell	NULL
preparations	NULL
were	NULL
then	NULL
stained	NULL
with	NULL
CD18-FITC	NULL
and	NULL
CD8-PE	NULL
,	NULL
and	NULL
PE-positive	NULL
cells	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
FACS	NULL
(	NULL
Coulter	NULL
EPICS	NULL
Elite	NULL
ESP	NULL
)	NULL
into	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
and	NULL
CD18	NULL
``	NULL
populations	NULL
based	NULL
on	NULL
CD18-FITC	NULL
fluorescence	NULL
intensity	NULL
(	NULL
CD18®	NULL
``	NULL
®**	NULL
cells	NULL
routinely	NULL
had	NULL
a	NULL
CD18-FITC	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
5-6	NULL
times	NULL
greater	NULL
than	NULL
CD18	NULL
``	NULL
cells	NULL
)	NULL
.	NULL

Another	NULL
method	NULL
for	NULL
obtaining	NULL
CD18	NULL
``	NULL
``	NULL
®**	NULL
T	NULL
cells	NULL
involved	NULL
the	NULL
use	NULL
of	NULL
PBMC	NULL
depleted	NULL
of	NULL
monocytes	NULL
alone	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
CD18-FITC	NULL
as	NULL
well	NULL
as	NULL
PE-conjugated	NULL
anti-CD56	NULL
and	NULL
anti-CD20	NULL
Abs	NULL
.	NULL

PE-nega-tive	NULL
cells	NULL
were	NULL
then	NULL
sorted	NULL
based	NULL
on	NULL
CD18-FITC	NULL
fluorescence	NULL
intensity	NULL
.	NULL

Through	NULL
this	NULL
method	NULL
,	NULL
CD18	NULL
``	NULL
®**	NULL
T	NULL
cells	NULL
were	NULL
0	NULL
%	NULL
CD56*	NULL
,	NULL
100	NULL
%	NULL
CD3*	NULL
,	NULL
95-98	NULL
%	NULL
TCR	NULL
«	NULL
B*	NULL
,	NULL
and	NULL
>	NULL
90	NULL
%	NULL
CD8*	NULL
.	NULL

Cell	NULL
sorting	NULL
routinely	NULL
yielded	NULL
a	NULL
maximum	NULL
of	NULL
3-4	NULL
X	NULL
10°	NULL
CD18®	NULL
``	NULL
®	NULL
``	NULL
*	NULL
and	NULL
CD18	NULL
``	NULL
T	NULL
cells/experiment	NULL
.	NULL

T	NULL
cell	NULL
stimulation	NULL
and	NULL
preparation	NULL
of	NULL
whole	NULL
cell	NULL
lysates	NULL
for	NULL
Western	NULL
blots	NULL
Sorted	NULL
T	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
stimulated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
800	NULL
pl	NULL
under	NULL
the	NULL
following	NULL
conditions	NULL
:	NULL
medium	NULL
alone	NULL
(	NULL
RPMI	NULL
1640	NULL
and	NULL
2.5	NULL
%	NULL
FCS	NULL
)	NULL
,	NULL
100	NULL
pM	NULL
IL-12	NULL
,	NULL
100	NULL
pM	NULL
IL-2	NULL
,	NULL
or	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
.	NULL

Approximately	NULL
0.75-1.0	NULL
X	NULL
10°	NULL
sorted	NULL
T	NULL
cells	NULL
were	NULL
used	NULL
per	NULL
condition	NULL
.	NULL

For	NULL
experiments	NULL
involving	NULL
the	NULL
p38	NULL
MAP	NULL
kinase	NULL
inhibitor	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
with	NULL
either	NULL
1-10	NULL
M	NULL
$	NULL
B203580	NULL
or	NULL
DMSO	NULL
vehicle	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
before	NULL
addition	NULL
of	NULL
cytokine	NULL
.	NULL

For	NULL
experiments	NULL
involving	NULL
the	NULL
MEK	NULL
inhibitor	NULL
PD98059	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
50	NULL
uM	NULL
PD98059	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
before	NULL
addition	NULL
of	NULL
cytokine	NULL
.	NULL

For	NULL
experiments	NULL
with	NULL
PMA	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
CD8-enriched	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
100	NULL
ng/ml	NULL
PMA	NULL
for	NULL
15	NULL
min	NULL
.	NULL

After	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
ice-cold	NULL
PBS	NULL
and	NULL
then	NULL
lysed	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
in	NULL
lysis	NULL
buffer	NULL
containing	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
50	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
pg/ml	NULL
aprotinin	NULL
,	NULL
100	NULL
ug/ml	NULL
PMSF	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
NaF	NULL
.	NULL

Whole	NULL
cell	NULL
lysates	NULL
were	NULL
mixed	NULL
with	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
2	NULL
%	NULL
reducing	NULL
sample	NULL
buffer	NULL
and	NULL
boiled	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

For	NULL
Western	NULL
blots	NULL
,	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Schleicher	NULL
and	NULL
Schuell	NULL
,	NULL
Keene	NULL
,	NULL
NH	NULL
)	NULL
by	NULL
electroblotting	NULL
,	NULL
and	NULL
membranes	NULL
were	NULL
then	NULL
blocked	NULL
for	NULL
30	NULL
min	NULL
in	NULL
Tris-buffered	NULL
saline	NULL
containing	NULL
0.1	NULL
%	NULL
Tween-20	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
either	NULL
5	NULL
%	NULL
BSA	NULL
(	NULL
U.S.	NULL
Biochemical	NULL
Corp.	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
or	NULL
5	NULL
%	NULL
nonfat	NULL
dried	NULL
milk	NULL
.	NULL

Membranes	NULL
were	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4474	NULL
incubated	NULL
with	NULL
dilutions	NULL
of	NULL
the	NULL
indicated	NULL
Abs	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
washed	NULL
with	NULL
Tris-buffered	NULL
saline/Tween-20	NULL
,	NULL
incubated	NULL
with	NULL
either	NULL
horseradish	NULL
peroxidase-conjugated	NULL
rabbit	NULL
anti-mouse	NULL
or	NULL
goat	NULL
anti-rabbit	NULL
Abs	NULL
(	NULL
di-luted	NULL
1/10,000	NULL
)	NULL
for	NULL
1	NULL
h	NULL
,	NULL
washed	NULL
again	NULL
,	NULL
and	NULL
developed	NULL
using	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
Amersham	NULL
,	NULL
Aylesbury	NULL
,	NULL
U.K.	NULL
)	NULL
.	NULL

When	NULL
reprobed	NULL
,	NULL
membranes	NULL
were	NULL
first	NULL
stripped	NULL
by	NULL
incubating	NULL
in	NULL
a	NULL
solution	NULL
containing	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
100	NULL
mM	NULL
2-ME	NULL
,	NULL
and	NULL
62.5	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
6.7	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
65°C	NULL
.	NULL

Proliferation	NULL
assays	NULL
and	NULL
measurement	NULL
of	NULL
IFN-y	NULL
production	NULL
Sorted	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
96-well	NULL
U-bottom	NULL
plates	NULL
at	NULL
3	NULL
X	NULL
10°	NULL
cells/	NULL
well	NULL
with	NULL
medium	NULL
alone	NULL
or	NULL
the	NULL
indicated	NULL
concentration	NULL
of	NULL
cytokines	NULL
at	NULL
37°C	NULL
.	NULL

For	NULL
experiments	NULL
involving	NULL
the	NULL
p38	NULL
MAP	NULL
kinase	NULL
inhibitor	NULL
,	NULL
1-10	NULL
uM	NULL
$	NULL
B203580	NULL
or	NULL
DMSO	NULL
vehicle	NULL
was	NULL
added	NULL
at	NULL
the	NULL
same	NULL
time	NULL
as	NULL
the	NULL
cytokines	NULL
.	NULL

Proliferation	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
and	NULL
consisted	NULL
of	NULL
a	NULL
96-h	NULL
incubation	NULL
,	NULL
with	NULL
1	NULL
[	NULL
H	NULL
]	NULL
thymidine	NULL
(	NULL
DuPont-New	NULL
England	NULL
Nuclear	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
added	NULL
8	NULL
h	NULL
before	NULL
harvesting	NULL
.	NULL

For	NULL
IFN-y	NULL
assays	NULL
,	NULL
supernatants	NULL
were	NULL
harvested	NULL
after	NULL
a	NULL
72-h	NULL
incubation	NULL
,	NULL
and	NULL
the	NULL
IFN-y	NULL
concentration	NULL
assayed	NULL
using	NULL
an	NULL
IFN-y	NULL
ELISA	NULL
(	NULL
Endogen	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Cytotoxicity	NULL
assays	NULL
Sorted	NULL
CD8	NULL
*	NULL
CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
first	NULL
incubated	NULL
overnight	NULL
in	NULL
96-well	NULL
,	NULL
U-bottom	NULL
plates	NULL
with	NULL
either	NULL
medium	NULL
alone	NULL
or	NULL
the	NULL
indicated	NULL
cytokines	NULL
at	NULL
37°C	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
target	NULL
cells	NULL
.	NULL

For	NULL
experiments	NULL
involving	NULL
the	NULL
p38	NULL
MAP	NULL
kinase	NULL
inhibitor	NULL
,	NULL
1-10	NULL
M	NULL
$	NULL
B203580	NULL
was	NULL
added	NULL
at	NULL
the	NULL
same	NULL
time	NULL
as	NULL
the	NULL
cytokines	NULL
.	NULL

COLO	NULL
or	NULL
OKT3	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
*'Cr	NULL
and	NULL
added	NULL
to	NULL
the	NULL
T	NULL
cells	NULL
at	NULL
a	NULL
5:1	NULL
E	NULL
:	NULL
T	NULL
cell	NULL
ratio	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
labeled	NULL
target	NULL
cells	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
harvested	NULL
.	NULL

*'Cr	NULL
release	NULL
was	NULL
assayed	NULL
using	NULL
a	NULL
gamma	NULL
counter	NULL
,	NULL
and	NULL
the	NULL
percent	NULL
specific	NULL
cytotoxicity	NULL
was	NULL
calculated	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Results	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
SAPK/INK	NULL
are	NULL
activated	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
in	NULL
CD18	NULL
``	NULL
T	NULL
cells	NULL
To	NULL
identify	NULL
the	NULL
signaling	NULL
pathways	NULL
that	NULL
mediate	NULL
the	NULL
functional	NULL
synergy	NULL
between	NULL
IL-12	NULL
and	NULL
IL-2	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
a	NULL
subset	NULL
of	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
that	NULL
are	NULL
unique	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
respond	NULL
to	NULL
these	NULL
cytokines	NULL
.	NULL

The	NULL
majority	NULL
of	NULL
freshly	NULL
isolated	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
additional	NULL
activation	NULL
,	NULL
do	NULL
not	NULL
respond	NULL
to	NULL
IL-12	NULL
,	NULL
IL-2	NULL
,	NULL
or	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

These	NULL
T	NULL
cells	NULL
have	NULL
a	NULL
naive	NULL
phenotype	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
relatively	NULL
weak	NULL
expression	NULL
of	NULL
CD18	NULL
(	NULL
CD18	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
identified	NULL
a	NULL
subset	NULL
of	NULL
CD8*	NULL
T	NULL
cells	NULL
(	NULL
CD8	NULL
*	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
``	NULL
)	NULL
that	NULL
express	NULL
intermediate	NULL
affinity	NULL
IL-2R	NULL
as	NULL
well	NULL
as	NULL
IL-12R	NULL
and	NULL
that	NULL
expand	NULL
in	NULL
vivo	NULL
in	NULL
cancer	NULL
patients	NULL
receiving	NULL
IL-12	NULL
(	NULL
37	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
,	NULL
these	NULL
T	NULL
cells	NULL
respond	NULL
weakly	NULL
to	NULL
IL-12	NULL
or	NULL
IL-2	NULL
alone	NULL
.	NULL

However	NULL
,	NULL
they	NULL
are	NULL
strongly	NULL
activated	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
to	NULL
proliferate	NULL
and	NULL
produce	NULL
IFN-y	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
stimulation	NULL
of	NULL
these	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
with	NULL
IL-12	NULL
and	NULL
IL-2	NULL
augments	NULL
non-MHC-restricted	NULL
as	NULL
well	NULL
as	NULL
CD3-mediated	NULL
killing	NULL
of	NULL
tumor	NULL
cells	NULL
.	NULL

Recent	NULL
reports	NULL
have	NULL
suggested	NULL
that	NULL
small	NULL
subpopulations	NULL
of	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
in	NULL
mice	NULL
,	NULL
including	NULL
Val4	NULL
NKT	NULL
cells	NULL
and	NULL
CD8	NULL
``	NULL
CD44	NULL
``	NULL
T	NULL
cells	NULL
,	NULL
may	NULL
mediate	NULL
the	NULL
antitumor	NULL
effect	NULL
of	NULL
IL-12	NULL
(	NULL
38	NULL
)	NULL
and	NULL
virus-induced	NULL
bystander	NULL
T	NULL
cell	NULL
proliferation	NULL
(	NULL
39	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
humans	NULL
,	NULL
the	NULL
CD8	NULL
T	NULL
cells	NULL
may	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
both	NULL
innate	NULL
and	NULL
acquired	NULL
immunity	NULL
to	NULL
infectious	NULL
pathogens	NULL
and	NULL
tumors	NULL
by	NULL
virtue	NULL
of	NULL
their	NULL
dual	NULL
ability	NULL
to	NULL
undergo	NULL
TCR-independent	NULL
activation	NULL
via	NULL
stimulation	NULL
with	NULL
cytokine	NULL
combinations	NULL
such	NULL
as	NULL
IL-12	NULL
and	NULL
IL-2	NULL
or	NULL
IL-12	NULL
and	NULL
IL-15	NULL
and	NULL
to	NULL
be	NULL
activated	NULL
through	NULL
the	NULL
TCR	NULL
by	NULL
specific	NULL
Ags	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
these	NULL
T	NULL
cells	NULL
may	NULL
mediate	NULL
the	NULL
antitumor	NULL
effect	NULL
of	NULL
cytokines	NULL
such	NULL
as	NULL
IL-12	NULL
and	NULL
IL-2	NULL
that	NULL
are	NULL
administered	NULL
to	NULL
patients	NULL
with	NULL
cancer	NULL
.	NULL

As	NULL
CD8*CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
can	NULL
uniquely	NULL
respond	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
without	NULL
first	NULL
requiring	NULL
additional	NULL
in	NULL
vitro	NULL
activation	NULL
with	NULL
mitogens	NULL
or	NULL
CD3	NULL
ligation	NULL
(	NULL
37	NULL
)	NULL
,	NULL
the	NULL
signaling	NULL
pathways	NULL
triggered	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
can	NULL
be	NULL
analyzed	NULL
without	NULL
concern	NULL
for	NULL
any	NULL
artifact	NULL
that	NULL
might	NULL
be	NULL
introduced	NULL
by	NULL
prior	NULL
in	NULL
vitro	NULL
manipulation	NULL
.	NULL

To	NULL
explore	NULL
whether	NULL
signaling	NULL
events	NULL
induced	NULL
by	NULL
IL-12	NULL
,	NULL
IL-2	NULL
,	NULL
or	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
differed	NULL
between	NULL
CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
*	NULL
and	NULL
IL-12/IL-2	NULL
SYNERGISM	NULL
INVOLVES	NULL
p38	NULL
MAP	NULL
KINASE/STAT	NULL
ACTIVATION	NULL
A	NULL
IL-12	NULL
+	NULL
=	NULL
IL-12	NULL
IL-2	NULL
IL-2	NULL
116-	NULL
«	NULL
meme	NULL
.	NULL

w	NULL
a	NULL
ld	NULL
-one	NULL
84-	NULL
z	NULL
a	NULL
a1	NULL
Blot	NULL
:	NULL
-phospho-tyrosine	NULL
``	NULL
-|	NULL
ee	NULL
ﬁ	NULL
ye	NULL
1	NULL
2	NULL
3	NULL
4	NULL
B	NULL
IL-12	NULL
+	NULL
F	NULL
IL-12	NULL
IL-2	NULL
-	NULL
IL-2	NULL
,	NULL
;	NULL
_	NULL
@	NULL
.~	NULL
a	NULL
36.5-	NULL
o	NULL
Rik	NULL
«	NULL
«	NULL
«	NULL
--	NULL
_	NULL
Blot	NULL
:	NULL
c-phospho-tyrosine	NULL
.	NULL

.	NULL

24	NULL
-	NULL
h	NULL
~~	NULL
_-	NULL
omi	NULL
1	NULL
2	NULL
3	NULL
4	NULL
FIGURE	NULL
1	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
Combined	NULL
stimulation	NULL
with	NULL
IL-12	NULL
and	NULL
IL-2	NULL
synergistically	NULL
augments	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
proteins	NULL
in	NULL
the	NULL
25-40	NULL
kDa	NULL
range	NULL
.	NULL

Sorted	NULL
CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
,	NULL
100	NULL
pM	NULL
IL-12	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
,	NULL
100	NULL
pM	NULL
IL-2	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
IL-12	NULL
and	NULL
IL-2	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
and	NULL
then	NULL
lysed	NULL
with	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
lysis	NULL
buffer	NULL
.	NULL

A	NULL
Western	NULL
blot	NULL
was	NULL
then	NULL
performed	NULL
on	NULL
whole	NULL
cell	NULL
lysates	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cells/	NULL
lane	NULL
)	NULL
using	NULL
an	NULL
anti-phosphotyrosine	NULL
Ab	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
separate	NULL
experiments	NULL
.	NULL

CD18	NULL
``	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
first	NULL
examined	NULL
the	NULL
pattern	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
these	NULL
cytokines	NULL
.	NULL

CD8	NULL
*CD18°	NULL
``	NULL
``	NULL
=	NULL
``	NULL
*	NULL
and	NULL
CD8	NULL
``	NULL
CD18	NULL
``	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
separately	NULL
through	NULL
FACS	NULL
and	NULL
stimulated	NULL
with	NULL
medium	NULL
alone	NULL
,	NULL
IL-12	NULL
,	NULL
IL-2	NULL
,	NULL
or	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
a	NULL
Western	NULL
blot	NULL
was	NULL
performed	NULL
on	NULL
whole	NULL
cell	NULL
lysates	NULL
using	NULL
a	NULL
phosphotyrosine-specific	NULL
Ab	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
although	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
several	NULL
proteins	NULL
in	NULL
the	NULL
60-130	NULL
kDa	NULL
range	NULL
was	NULL
observed	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
there	NULL
was	NULL
no	NULL
further	NULL
increase	NULL
in	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
those	NULL
proteins	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
and	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
several	NULL
proteins	NULL
in	NULL
the	NULL
range	NULL
of	NULL
25-42	NULL
kDa	NULL
were	NULL
strongly	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
but	NULL
were	NULL
only	NULL
weakly	NULL
tyrosine	NULL
phosphorylated	NULL
or	NULL
were	NULL
not	NULL
phosphorylated	NULL
at	NULL
all	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
,	NULL
IL-2	NULL
,	NULL
or	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
CD18	NULL
``	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
proteins	NULL
in	NULL
the	NULL
38-42	NULL
kDa	NULL
range	NULL
in	NULL
response	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
activation	NULL
of	NULL
ERK1/ERK2	NULL
(	NULL
p44/p42	NULL
)	NULL
or	NULL
p38	NULL
MAP	NULL
kinase	NULL
in	NULL
CD8	NULL
*CD18°	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
was	NULL
in	NULL
part	NULL
mediating	NULL
the	NULL
functional	NULL
synergy	NULL
between	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
IL-12	NULL
or	NULL
IL-2	NULL
could	NULL
activate	NULL
a	NULL
MAP	NULL
kinase	NULL
family	NULL
mem-ber	NULL
,	NULL
sorted	NULL
CD18	NULL
``	NULL
and	NULL
CD18	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
medium	NULL
alone	NULL
,	NULL
IL-12	NULL
,	NULL
IL-2	NULL
,	NULL
or	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
.	NULL

Western	NULL
blots	NULL
were	NULL
performed	NULL
on	NULL
whole	NULL
cell	NULL
lysates	NULL
using	NULL
Abs	NULL
that	NULL
recognize	NULL
the	NULL
activated	NULL
,	NULL
phosphorylated	NULL
forms	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
,	NULL
SAPK/JNK	NULL
,	NULL
or	NULL
ERK1/ERK2	NULL
.	NULL

Low	NULL
level	NULL
,	NULL
constitutive	NULL
activation	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
was	NULL
present	NULL
in	NULL
CD18	NULL
``	NULL
and	NULL
CD18	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Neither	NULL
IL-12	NULL
nor	NULL
IL-2	NULL
alone	NULL
consistently	NULL
activated	NULL
p38	NULL
MAP	NULL
kinase	NULL
in	NULL
CD18	NULL
``	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
or	NULL
CD18	NULL
``	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
stimulation	NULL
of	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
markedly	NULL
increased	NULL
the	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
FIGURE	NULL
2.	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
A	NULL
SAPK/JINK	NULL
are	NULL
activated	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
whereas	NULL
ERK1	NULL
CD1	NULL
gbright	NULL
4475	NULL
CD1§8dim	NULL
and	NULL
ERK2	NULL
are	NULL
not	NULL
.	NULL

A	NULL
,	NULL
p38	NULL
MAP	NULL
kinase	NULL
is	NULL
activated	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
in	NULL
CD18®	NULL
``	NULL
#	NULL
``	NULL
T	NULL
cells	NULL
.	NULL

Sorted	NULL
CD18	NULL
``	NULL
®*	NULL
or	NULL
CD18	NULL
``	NULL
T	NULL
=	NULL
cells	NULL
were	NULL
stimulated	NULL
and	NULL
lysed	NULL
as	NULL
de-	NULL
scribed	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

A	NULL
Western	NULL
blot	NULL
was	NULL
then	NULL
performed	NULL
on	NULL
whole	NULL
cell	NULL
lysates	NULL
us	NULL
ing	NULL
an	NULL
Ab	NULL
that	NULL
recognizes	NULL
the	NULL
activated	NULL
,	NULL
phosphorylated	NULL
form	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
protein	NULL
in	NULL
each	NULL
lane	NULL
was	NULL
determined	NULL
by	NULL
stripping	NULL
the	NULL
membrane	NULL
and	NULL
B	NULL
reprobing	NULL
with	NULL
an	NULL
Ab	NULL
that	NULL
recognizes	NULL
to	NULL
tal	NULL
p38	NULL
MAP	NULL
kinase	NULL
regardless	NULL
of	NULL
its	NULL
phosphorylation	NULL
state	NULL
(	NULL
Lower	NULL
panel	NULL
)	NULL
.	NULL

Sim-	NULL
ilar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
four	NULL
separate	NULL
experiments	NULL
using	NULL
cells	NULL
from	NULL
different	NULL
do	NULL
nors	NULL
.	NULL

B	NULL
,	NULL
SAPK/JNK	NULL
is	NULL
activated	NULL
by	NULL
IL-12	NULL
.	NULL

and	NULL
IL-2	NULL
in	NULL
CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

Sorted	NULL
*	NULL
cells	NULL
were	NULL
stimulated	NULL
and	NULL
lysed	NULL
as	NULL
de-	NULL
pS4-	NULL
»	NULL
scribed	NULL
in	NULL
A	NULL
,	NULL
and	NULL
Western	NULL
blots	NULL
were	NULL
performed	NULL
with	NULL
Abs	NULL
specific	NULL
for	NULL
the	NULL
activated	NULL
,	NULL
phosphorylated	NULL
form	NULL
of	NULL
SAPK/	NULL
JNK	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
total	NULL
SAPK/INK	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Arrows	NULL
point	NULL
to	NULL
the	NULL
two	NULL
SAPK/JINK	NULL
isoforms	NULL
.	NULL

Lane	NULL
9	NULL
serves	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
and	NULL
contains	NULL
the	NULL
lysate	NULL
from	NULL
CD8	NULL
*CD18	NULL
``	NULL
*	NULL
``	NULL
*	NULL
and	NULL
CD8	NULL
*	NULL
CD18	NULL
``	NULL
1	NULL
2	NULL
3	NULL
T	NULL
cells	NULL
stimulated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
PMA	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
four	NULL
sepa-	NULL
c	NULL
rate	NULL
experiments	NULL
using	NULL
cells	NULL
from	NULL
different	NULL
donors	NULL
.	NULL

C	NULL
,	NULL
ERK1	NULL
and	NULL
ERK2	NULL
are	NULL
not	NULL
acti-	NULL
IL-12	NULL
-	NULL
IL-2	NULL
p46-	NULL
»	NULL
CD1	NULL
Bbright	NULL
vated	NULL
.	NULL

by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
in	NULL
CD18®	NULL
``	NULL
T	NULL
IL-12	NULL
cells	NULL
.	NULL

Sorted	NULL
cells	NULL
were	NULL
stimulated	NULL
as	NULL
described	NULL
in	NULL
A	NULL
,	NULL
and	NULL
Western	NULL
blots	NULL
were	NULL
performed	NULL
with	NULL
Abs	NULL
specific	NULL
for	NULL
the	NULL
activated	NULL
,	NULL
phosphorylated	NULL
forms	NULL
of	NULL
ERK1/ERK2	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
total	NULL
ERK1/ERK2	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
from	NULL
four	NULL
separate	NULL
experiments	NULL
using	NULL
cells	NULL
from	NULL
different	NULL
donors	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
stimulation	NULL
of	NULL
CD18	NULL
``	NULL
T	NULL
cells	NULL
with	NULL
IL-12	NULL
and	NULL
IL-2	NULL
did	NULL
not	NULL
augment	NULL
p38	NULL
MAP	NULL
kinase	NULL
phosphorylation	NULL
over	NULL
the	NULL
basal	NULL
level	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
Zane	NULL
8	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
differential	NULL
effect	NULL
of	NULL
the	NULL
IL-12	NULL
and	NULL
IL-2	NULL
combination	NULL
on	NULL
p38	NULL
MAP	NULL
kinase	NULL
activation	NULL
in	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
and	NULL
CD18	NULL
``	NULL
cells	NULL
,	NULL
p38	NULL
MAP	NULL
kinase	NULL
expression	NULL
was	NULL
also	NULL
much	NULL
higher	NULL
in	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
compared	NULL
with	NULL
CD18	NULL
``	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lower	NULL
panel	NULL
.	NULL

A	NULL
similar	NULL
pattern	NULL
of	NULL
activation	NULL
was	NULL
observed	NULL
for	NULL
SAPK/JNK	NULL
.	NULL

Whereas	NULL
low	NULL
level	NULL
constitutive	NULL
activation	NULL
was	NULL
seen	NULL
in	NULL
CD18	NULL
``	NULL
=*	NULL
``	NULL
*	NULL
and	NULL
CD18	NULL
``	NULL
subsets	NULL
,	NULL
strong	NULL
activation	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
of	NULL
the	NULL
p54	NULL
and	NULL
p46	NULL
SAPK/JNK	NULL
isoforms	NULL
occurred	NULL
only	NULL
in	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
with	NULL
p38	NULL
MAP	NULL
kinase	NULL
,	NULL
SAPK/	NULL
JNK	NULL
expression	NULL
was	NULL
similar	NULL
in	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
and	NULL
CD18	NULL
``	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
IL-2	NULL
and	NULL
IL-12	NULL
can	NULL
activate	NULL
ERK1/ERK2	NULL
in	NULL
mitogen-activated	NULL
T	NULL
cells	NULL
,	NULL
no	NULL
activation	NULL
of	NULL
ERK1	NULL
or	NULL
ERK2	NULL
was	NULL
detected	NULL
in	NULL
CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
*	NULL
``	NULL
*	NULL
or	NULL
CD18	NULL
``	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
,	NULL
IL-2	NULL
,	NULL
or	NULL
IL-12	NULL
and	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

This	NULL
was	NULL
not	NULL
due	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
ERK1/ERK2	NULL
,	NULL
as	NULL
similar	NULL
amounts	NULL
of	NULL
ERK1	NULL
and	NULL
ERK2	NULL
were	NULL
present	NULL
in	NULL
CD8	NULL
*CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
*	NULL
and	NULL
CD8	NULL
``	NULL
CD18	NULL
``	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

This	NULL
was	NULL
also	NULL
not	NULL
due	NULL
to	NULL
a	NULL
defect	NULL
in	NULL
the	NULL
ERK	NULL
signaling	NULL
pathway	NULL
,	NULL
as	NULL
the	NULL
phorbol	NULL
ester	NULL
PMA	NULL
was	NULL
able	NULL
to	NULL
activate	NULL
ERK2	NULL
in	NULL
these	NULL
same	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

IL-12	NULL
IL-2	NULL
=	NULL
«	NULL
amt	NULL
CDISbrighl	NULL
IL-12	NULL
IL-2	NULL
IL-2	NULL
=	NULL
+	NULL
=	NULL
IL-12	NULL
IL-2	NULL
_	NULL
IL-2	NULL
ots	NULL
.	NULL

comme	NULL
.	NULL

onle	NULL
elli	NULL
.	NULL

<	NULL
e	NULL
<	NULL
ommme	NULL
ommne	NULL
<	NULL
p	NULL
<	NULL
>	NULL
a	NULL
»	NULL
GD	NULL
-	NULL
c	NULL
»	NULL
con	NULL
come	NULL
come	NULL
IL-12	NULL
+	NULL
+	NULL
IL-12	NULL
-	NULL
IL-2	NULL
IL-2	NULL
Blot	NULL
:	NULL
-phospho-p38	NULL
MAP	NULL
Kinase	NULL
Blot	NULL
:	NULL
MAP	NULL
Kinase	NULL
CD184i=m	NULL
CD1gbright	NULL
and	NULL
IL-12	NULL
IL-12	NULL
-	NULL
CD18	NULL
!	NULL

=	NULL
+	NULL
+	NULL
+	NULL
IL-12	NULL
IL-2	NULL
IL-2	NULL
pma	NULL
&	NULL
_	NULL
Blot	NULL
:	NULL
-phospho-	NULL
[	NULL
3	NULL
SAPK/JNK	NULL
Blot	NULL
:	NULL
a-SAPK/JNK	NULL
#	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
CD1g®0	NULL
@	NULL
n	NULL
and	NULL
CDig	NULL
!	NULL

®	NULL
+	NULL
CD18¢n	NULL
IL-12	NULL
+	NULL
--	NULL
L412	NULL
IL20	NULL
dL2	NULL
pma	NULL
«	NULL
ip	NULL
Blot	NULL
:	NULL
c-phospho-ERK1/2	NULL
a	NULL
»	NULL
«	NULL
lp	NULL
Blot	NULL
:	NULL
c-ERK1/2	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
Having	NULL
observed	NULL
that	NULL
p38	NULL
MAP	NULL
kinase	NULL
is	NULL
differentially	NULL
expressed	NULL
in	NULL
CD18	NULL
``	NULL
and	NULL
CD18	NULL
``	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
strongly	NULL
activated	NULL
by	NULL
stimulation	NULL
with	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
in	NULL
CD18	NULL
``	NULL
cells	NULL
alone	NULL
,	NULL
we	NULL
next	NULL
determined	NULL
whether	NULL
other	NULL
proximal	NULL
and	NULL
distal	NULL
components	NULL
of	NULL
the	NULL
p38	NULL
MAP	NULL
kinase	NULL
pathway	NULL
were	NULL
also	NULL
activated	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

The	NULL
dual	NULL
spec-ificity	NULL
protein	NULL
kinases	NULL
MKK3	NULL
and	NULL
MKK6	NULL
are	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
cellular	NULL
stresses	NULL
or	NULL
inflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1	NULL
and	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
selectively	NULL
activate	NULL
p38	NULL
MAP	NULL
kinase	NULL
through	NULL
phosphorylation	NULL
on	NULL
tyrosine	NULL
and	NULL
threonine	NULL
residues	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

In	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
there	NULL
was	NULL
low	NULL
level	NULL
basal	NULL
activation	NULL
of	NULL
MKK3/6	NULL
,	NULL
which	NULL
was	NULL
not	NULL
appreciably	NULL
augmented	NULL
with	NULL
stimulation	NULL
by	NULL
IL-12	NULL
or	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
1-3	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

However	NULL
,	NULL
stimulation	NULL
with	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
strongly	NULL
activated	NULL
MKK3/6	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
the	NULL
synergistic	NULL
activation	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
was	NULL
mediated	NULL
through	NULL
MKK3/6	NULL
.	NULL

Both	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
SAPK/JNK	NULL
activate	NULL
ATF-2	NULL
through	NULL
the	NULL
phosphorylation	NULL
of	NULL
threonine	NULL
residues	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
the	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
SAPK/JNK	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
augmented	NULL
the	NULL
activity	NULL
of	NULL
these	NULL
serine/threonine	NULL
kinases	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
ATF-2	NULL
phosphorylation	NULL
was	NULL
increased	NULL
by	NULL
stimulation	NULL
with	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

As	NULL
was	NULL
observed	NULL
with	NULL
MKK3/6	NULL
,	NULL
there	NULL
was	NULL
low	NULL
level	NULL
basal	NULL
phosphorylation	NULL
of	NULL
ATF-2	NULL
in	NULL
CD18	NULL
``	NULL
=	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
1	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
which	NULL
was	NULL
greatly	NULL
augmented	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
plus	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4476	NULL
IL-12	NULL
+	NULL
=	NULL
IL-12	NULL
IL-2	NULL
IL-2	NULL
Sy	NULL
B	NULL
>	NULL
.	NULL

Blot	NULL
:	NULL
*	NULL
-an	NULL
.	NULL

Blot	NULL
:	NULL
o-phospho-ATF-2	NULL
1	NULL
2	NULL
3	NULL
4	NULL
FIGURE	NULL
3	NULL
.	NULL

MKK3/MKK6	NULL
and	NULL
ATF-2	NULL
are	NULL
synergistically	NULL
activated	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

Sorted	NULL
CD8	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
medium	NULL
alone	NULL
,	NULL
IL-12	NULL
,	NULL
IL-2	NULL
,	NULL
or	NULL
IL-12	NULL
and	NULL
IL-2	NULL
and	NULL
lysed	NULL
.	NULL

Western	NULL
blots	NULL
were	NULL
performed	NULL
on	NULL
whole	NULL
cell	NULL
lysates	NULL
using	NULL
an	NULL
Ab	NULL
specific	NULL
for	NULL
the	NULL
activated	NULL
,	NULL
phosphorylated	NULL
form	NULL
of	NULL
MKK3/MKK6	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
an	NULL
Ab	NULL
specific	NULL
for	NULL
the	NULL
phosphorylated	NULL
form	NULL
of	NULL
ATF-2	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
separate	NULL
experiments	NULL
.	NULL

IL-2	NULL
(	NULL
lane	NULL
4	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
but	NULL
not	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
or	NULL
IL-2	NULL
alone	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
SAPK/JNK	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
plus	NULL
IL-12	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
phosphorylation	NULL
of	NULL
a	NULL
physiologic	NULL
substrate	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
serine	NULL
phosphorylation	NULL
,	NULL
but	NULL
not	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
is	NULL
synergistically	NULL
increased	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
in	NULL
CD18	NULL
``	NULL
T	NULL
cells	NULL
In	NULL
addition	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
components	NULL
of	NULL
MAP	NULL
kinase	NULL
family	NULL
pathways	NULL
,	NULL
signaling	NULL
through	NULL
cytokine	NULL
receptors	NULL
in	NULL
lymphocytes	NULL
also	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
components	NULL
of	NULL
the	NULL
JAK/STAT	NULL
pathway	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
could	NULL
augment	NULL
STAT	NULL
activation	NULL
in	NULL
CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
as	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
SAPK/JNK	NULL
activation	NULL
,	NULL
we	NULL
stimulated	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
and	NULL
CD18	NULL
``	NULL
T	NULL
cells	NULL
with	NULL
IL-12	NULL
,	NULL
IL-2	NULL
,	NULL
or	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
.	NULL

The	NULL
cytokine-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
,	NULL
STAT5	NULL
,	NULL
and	NULL
STAT3	NULL
was	NULL
then	NULL
analyzed	NULL
by	NULL
performing	NULL
Western	NULL
blots	NULL
on	NULL
whole	NULL
cell	NULL
lysates	NULL
using	NULL
Abs	NULL
that	NULL
specifically	NULL
recognize	NULL
the	NULL
tyrosine-phosphorylated	NULL
forms	NULL
of	NULL
these	NULL
STAT	NULL
's	NULL
.	NULL

No	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
,	NULL
STAT5	NULL
,	NULL
or	NULL
STAT3	NULL
was	NULL
observed	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
and/or	NULL
IL-2	NULL
in	NULL
sorted	NULL
CD18	NULL
``	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Among	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
IL-12	NULL
and	NULL
IL-2	NULL
each	NULL
induced	NULL
the	NULL
weak	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

IL-2	NULL
,	NULL
but	NULL
not	NULL
IL-12	NULL
,	NULL
induced	NULL
the	NULL
relatively	NULL
strong	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STATS	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Stimulation	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
did	NULL
not	NULL
further	NULL
increase	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
these	NULL
STATs	NULL
over	NULL
that	NULL
which	NULL
was	NULL
observed	NULL
with	NULL
IL-12	NULL
or	NULL
IL-2	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
functional	NULL
synergy	NULL
between	NULL
IL-2	NULL
and	NULL
IL-12	NULL
is	NULL
not	NULL
associated	NULL
with	NULL
changes	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
these	NULL
STAT	NULL
's	NULL
.	NULL

Given	NULL
our	NULL
findings	NULL
of	NULL
enhanced	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
SAPK/	NULL
JNK	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
on	NULL
the	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
's	NULL
using	NULL
Abs	NULL
that	NULL
specifically	NULL
recognize	NULL
the	NULL
serine-phosphorylated	NULL
forms	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
.	NULL

Stimulation	NULL
of	NULL
sorted	NULL
CD18	NULL
T	NULL
cells	NULL
with	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
alone	NULL
or	NULL
together	NULL
,	NULL
did	NULL
not	NULL
result	NULL
in	NULL
the	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
or	NULL
STAT3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
stimulation	NULL
of	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
with	NULL
IL-12	NULL
or	NULL
IL-2	NULL
weakly	NULL
increased	NULL
the	NULL
serine	NULL
phosphorylation	NULL
of	NULL
both	NULL
STAT1	NULL
and	NULL
STAT3	NULL
over	NULL
the	NULL
basal	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
upper	NULL
panels	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
combined	NULL
stimulation	NULL
with	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
resulted	NULL
in	NULL
a	NULL
striking	NULL
increase	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
STAT1	NULL
and	NULL
IL-12/IL-2	NULL
SYNERGISM	NULL
INVOLVES	NULL
p38	NULL
MAP	NULL
KINASE/STAT	NULL
ACTIVATION	NULL
A	NULL
IL-12	NULL
+	NULL
=	NULL
IL-12	NULL
IL-2	NULL
IL-2	NULL
«	NULL
-	NULL
o-phospho-Stat5	NULL
<	NULL
-	NULL
a-phospho-Static	NULL
<	NULL
4-	NULL
a-phospho-Statif	NULL
1	NULL
2	NULL
3	NULL
4	NULL
IL-12	NULL
+	NULL
=	NULL
IL-12	NULL
IL-2	NULL
IL-2	NULL
ous	NULL
-	NULL
e.	NULL
<	NULL
--	NULL
o-phospho-Stat3	NULL
1	NULL
2	NULL
3	NULL
4	NULL
FIGURE	NULL
4	NULL
.	NULL

T	NULL
cell	NULL
activation	NULL
with	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
does	NULL
not	NULL
augment	NULL
STAT	NULL
tyrosine	NULL
phosphorylation	NULL
beyond	NULL
that	NULL
which	NULL
is	NULL
observed	NULL
with	NULL
either	NULL
cytokine	NULL
alone	NULL
.	NULL

Sorted	NULL
CD18°	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
activated	NULL
with	NULL
either	NULL
medium	NULL
alone	NULL
or	NULL
the	NULL
indicated	NULL
cytokines	NULL
and	NULL
lysed	NULL
.	NULL

Western	NULL
blots	NULL
were	NULL
performed	NULL
on	NULL
whole	NULL
cell	NULL
lysates	NULL
using	NULL
either	NULL
an	NULL
Ab	NULL
that	NULL
recognizes	NULL
the	NULL
tyrosine-phosphorylated	NULL
forms	NULL
of	NULL
STAT1	NULL
&	NULL
@	NULL
/STAT1R	NULL
and	NULL
STATS	NULL
(	NULL
4	NULL
)	NULL
or	NULL
the	NULL
tyrosine-phosphorylated	NULL
form	NULL
of	NULL
STAT3	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
separate	NULL
experiments	NULL
.	NULL

STAT3	NULL
serine	NULL
phosphorylation	NULL
over	NULL
that	NULL
observed	NULL
with	NULL
either	NULL
cytokine	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
upper	NULL
panels	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

This	NULL
increase	NULL
in	NULL
STAT1	NULL
and	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
was	NULL
not	NULL
due	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
STAT1	NULL
or	NULL
STAT3	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
lower	NULL
panels	NULL
)	NULL
.	NULL

An	NULL
inhibitor	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
abrogates	NULL
the	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
,	NULL
while	NULL
a	NULL
MEK	NULL
inhibitor	NULL
has	NULL
no	NULL
effect	NULL
Since	NULL
the	NULL
augmentation	NULL
of	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
in	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
strong	NULL
increase	NULL
in	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
SAPK/JNK	NULL
activation	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
we	NULL
hypothesized	NULL
that	NULL
one	NULL
or	NULL
both	NULL
of	NULL
these	NULL
serine/threonine	NULL
kinases	NULL
might	NULL
be	NULL
mediating	NULL
the	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
.	NULL

Although	NULL
a	NULL
specific	NULL
pharma-cologic	NULL
inhibitor	NULL
of	NULL
SAPK/JNK	NULL
is	NULL
not	NULL
available	NULL
,	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
(	NULL
$	NULL
B203580	NULL
)	NULL
has	NULL
been	NULL
described	NULL
.	NULL

The	NULL
p38	NULL
MAP	NULL
kinase	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
IL-2	NULL
in	NULL
a	NULL
murine	NULL
T	NULL
cell	NULL
line	NULL
(	NULL
16	NULL
)	NULL
and	NULL
by	NULL
TNF-a	NULL
in	NULL
L929	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
.	NULL

SB203580	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
M	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
maximally	NULL
inhibit	NULL
IL-2-induced	NULL
proliferation	NULL
and	NULL
TNF-	NULL
«	NULL
-induced	NULL
cytokine	NULL
production	NULL
in	NULL
these	NULL
cell	NULL
lines	NULL
.	NULL

Used	NULL
at	NULL
concentrations	NULL
ranging	NULL
from	NULL
0.1-1	NULL
mM	NULL
,	NULL
$	NULL
B203580	NULL
inhibits	NULL
the	NULL
IL-2-induced	NULL
activation	NULL
of	NULL
MAP	NULL
kinase	NULL
activating	NULL
protein	NULL
by	NULL
p38	NULL
MAP	NULL
kinase	NULL
without	NULL
inhibiting	NULL
the	NULL
IL-2-induced	NULL
activation	NULL
of	NULL
ATF-2	NULL
by	NULL
SAPK/JNK	NULL
in	NULL
a	NULL
murine	NULL
T	NULL
cell	NULL
line	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Even	NULL
at	NULL
SB203580	NULL
concentrations	NULL
of	NULL
10-20	NULL
uM	NULL
,	NULL
p38	NULL
MAP	NULL
kinase	NULL
is	NULL
selectively	NULL
inhibited	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
16	NULL
)	NULL
and	NULL
mouse	NULL
fibroblasts	NULL
(	NULL
44	NULL
)	NULL
,	NULL
while	NULL
ERK	NULL
and	NULL
SAPK/JNK	NULL
activity	NULL
remain	NULL
unaffected	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
p38	NULL
MAP	NULL
kinase	NULL
was	NULL
mediating	NULL
the	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
,	NULL
sorted	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
wM	NULL
$	NULL
B203580	NULL
or	NULL
vehicle	NULL
(	NULL
DMSO	NULL
)	NULL
alone	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

64	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
greatly	NULL
increased	NULL
the	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
and	NULL
STAT3	NULL
over	NULL
the	NULL
low	NULL
to	NULL
absent	NULL
basal	NULL
serine	NULL
phosphorylation	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
top	NULL
and	NULL
middle	NULL
panels	NULL
)	NULL
.	NULL

When	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
10	NULL
wM	NULL
$	NULL
B203580	NULL
alone	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
basal	NULL
STAT1	NULL
and	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
could	NULL
be	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
top	NULL
and	NULL
middle	NULL
panels	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
uM	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
FIGURE	NULL
5	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
strongly	NULL
augments	NULL
the	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
and	NULL
STAT3	NULL
.	NULL

Sorted	NULL
CD18°	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
medium	NULL
alone	NULL
or	NULL
the	NULL
indicated	NULL
cytokines	NULL
and	NULL
lysed	NULL
.	NULL

Western	NULL
blots	NULL
were	NULL
performed	NULL
using	NULL
either	NULL
an	NULL
Ab	NULL
that	NULL
specifically	NULL
recognizes	NULL
the	NULL
serine-phosphorylated	NULL
form	NULL
of	NULL
STAT3	NULL
(	NULL
4	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
an	NULL
Ab	NULL
that	NULL
recognizes	NULL
the	NULL
serine-phospho-	NULL
B	NULL
rylated	NULL
form	NULL
of	NULL
STAT1	NULL
(	NULL
B	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
four	NULL
separate	NULL
experiments	NULL
using	NULL
cells	NULL
from	NULL
different	NULL
volunteer	NULL
donors	NULL
.	NULL

$	NULL
B203580	NULL
,	NULL
the	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
was	NULL
completely	NULL
abolished	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
.	NULL

Similar	NULL
effects	NULL
on	NULL
basal	NULL
and	NULL
IL-12	NULL
plus	NULL
IL-2-induced	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
were	NULL
observed	NULL
A	NULL
medium	NULL
DMSO	NULL
$	NULL
B203580	NULL
IL-12	NULL
IL-12	NULL
IL-12	NULL
+	NULL
+	NULL
+	NULL
=	NULL
--	NULL
IL-2	NULL
=-	NULL
IL2	NULL
-	NULL
IL-2	NULL
t	NULL
«	NULL
wearse	NULL
Blot	NULL
:	NULL
o-phospho-serine	NULL
t	NULL
STATL	NULL
Blot	NULL
:	NULL
ss	NULL
«	NULL
emt	NULL
eme	NULL
me	NULL
STAT3	NULL
wu	NULL
sass	NULL
TBs	NULL
ts	NULL
UB	NULL
B	NULL
icu	NULL
:	NULL
c-STAT3	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
B	NULL
50	NULL
uM	NULL
PD98059	NULL
IL-12	NULL
+	NULL
L	NULL
IL-2	NULL
Blot	NULL
:	NULL
o-phospho-serine	NULL
STAT1	NULL
1	NULL
2	NULL
FIGURE	NULL
6	NULL
.	NULL

A	NULL
p38	NULL
MAP	NULL
kinase	NULL
inhibitor	NULL
(	NULL
$	NULL
B203580	NULL
)	NULL
blocks	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
,	NULL
whereas	NULL
the	NULL
MEK	NULL
inhibitor	NULL
PD98059	NULL
does	NULL
not	NULL
.	NULL

A	NULL
,	NULL
Sorted	NULL
CD8*CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
either	NULL
medium	NULL
alone	NULL
(	NULL
Zanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
)	NULL
or	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
)	NULL
and	NULL
lysed	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
10	NULL
wM	NULL
S	NULL
$	NULL
B203580	NULL
(	NULL
in	NULL
DMSO	NULL
)	NULL
or	NULL
DMSO	NULL
alone	NULL
before	NULL
the	NULL
15-min	NULL
incubation	NULL
with	NULL
medium	NULL
alone	NULL
or	NULL
cytokines	NULL
.	NULL

Western	NULL
blots	NULL
were	NULL
performed	NULL
on	NULL
whole	NULL
cell	NULL
lysates	NULL
using	NULL
either	NULL
an	NULL
Ab	NULL
that	NULL
recognizes	NULL
the	NULL
serine-phosphorylated	NULL
form	NULL
of	NULL
STAT1	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
or	NULL
an	NULL
Ab	NULL
that	NULL
recognizes	NULL
the	NULL
serine-phosphorylated	NULL
form	NULL
of	NULL
STAT3	NULL
(	NULL
middle	NULL
panel	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
Sorted	NULL
CD8	NULL
*	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
50	NULL
uM	NULL
PD98059	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
IL-12	NULL
and	NULL
IL-2	NULL
(	NULL
Jane	NULL
2	NULL
)	NULL
as	NULL
described	NULL
in	NULL
(	NULL
4	NULL
)	NULL
.	NULL

A	NULL
Western	NULL
blot	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
phosphoserine-STAT1	NULL
Ab	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
separate	NULL
experiments	NULL
.	NULL

4477	NULL
IL-12	NULL
+	NULL
IL-12	NULL
IL-2	NULL
_	NULL
IL-2	NULL
Mobeni	NULL
oe	NULL
Blot	NULL
:	NULL
c-phospho-serine	NULL
STAT3	NULL
Blot	NULL
:	NULL
Blot	NULL
:	NULL
oc-phospho-serine	NULL
STAT1	NULL
es	NULL
y	NULL
ag	NULL
:	NULL
Blot	NULL
:	NULL
a-STAT1	NULL
with	NULL
as	NULL
little	NULL
as	NULL
1	NULL
wM	NULL
SB203580	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
STAT	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
or	NULL
IL-2	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
$	NULL
B203580	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
p38	NULL
MAP	NULL
kinase	NULL
activity	NULL
was	NULL
necessary	NULL
for	NULL
STAT1	NULL
and	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

Since	NULL
neither	NULL
ERK	NULL
1	NULL
nor	NULL
ERK2	NULL
was	NULL
activated	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
it	NULL
was	NULL
unlikely	NULL
that	NULL
the	NULL
ERK	NULL
MAP	NULL
kinase	NULL
pathway	NULL
was	NULL
mediating	NULL
the	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

To	NULL
further	NULL
demonstrate	NULL
this	NULL
point	NULL
,	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
MEK	NULL
inhibitor	NULL
(	NULL
PD98059	NULL
)	NULL
,	NULL
which	NULL
prevents	NULL
the	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
ERK1/ERK2	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
the	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
and	NULL
IL-2	NULL
was	NULL
unaffected	NULL
by	NULL
PD98059	NULL
,	NULL
as	NULL
was	NULL
the	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
abolishes	NULL
the	NULL
functional	NULL
synergy	NULL
between	NULL
IL-12	NULL
and	NULL
IL-2	NULL
in	NULL
CD8¢	NULL
CD18	NULL
``	NULL
``	NULL
*	NULL
``	NULL
T	NULL
cells	NULL
To	NULL
determine	NULL
whether	NULL
the	NULL
activation	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
is	NULL
essential	NULL
to	NULL
the	NULL
functional	NULL
response	NULL
of	NULL
CD8	NULL
T	NULL
cells	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
sorted	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-12	NULL
and/or	NULL
IL-2	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
$	NULL
B203580	NULL
.	NULL

IFN-y	NULL
production	NULL
was	NULL
assessed	NULL
after	NULL
72	NULL
h	NULL
,	NULL
and	NULL
proliferation	NULL
was	NULL
assessed	NULL
after	NULL
96	NULL
h.	NULL
As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
proliferation	NULL
and	NULL
IFN-y	NULL
production	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
alone	NULL
or	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
was	NULL
almost	NULL
completely	NULL
inhibited	NULL
by	NULL
10	NULL
uM	NULL
$	NULL
B203580	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
non-MHC-restricted	NULL
cytolytic	NULL
activity	NULL
against	NULL
the	NULL
COLO	NULL
cell	NULL
line	NULL
induced	NULL
by	NULL
IL-12	NULL
or	NULL
IL-2	NULL
was	NULL
reduced	NULL
by	NULL
$	NULL
B203580	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
,	NULL
and	NULL
there	NULL
was	NULL
a	NULL
modest	NULL
50	NULL
%	NULL
reduction	NULL
in	NULL
cytotoxicity	NULL
induced	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
functional	NULL
responses	NULL
to	NULL
IL-2	NULL
or	NULL
IL-12	NULL
plus	NULL
IL-2	NULL
was	NULL
also	NULL
observed	NULL
with	NULL
1	NULL
uM	NULL
$	NULL
B203580	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
p38	NULL
MAP	NULL
kinase	NULL
inhibitor	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
IL-12-	NULL
or	NULL
IL-2-induced	NULL
augmentation	NULL
of	NULL
CD3-mediated	NULL
cytolytic	NULL
activity	NULL
against	NULL
the	NULL
OKT3	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
,	NULL
but	NULL
did	NULL
partially	NULL
inhibit	NULL
(	NULL
30	NULL
%	NULL
reduction	NULL
)	NULL
cytotoxicity	NULL
induced	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4478	NULL
A	NULL
10000	NULL
é	NULL
7500	NULL
a	NULL
3	NULL
B	NULL
S	NULL
&	NULL
DD-	NULL
5000	NULL
tz	NULL
t	NULL
.	NULL

§	NULL
E	NULL
#	NULL
_	NULL
2500	NULL
0	NULL
IL-12	NULL
IL-2	NULL
IL-12	NULL
+	NULL
IL-2	NULL
Cytokine	NULL
B	NULL
15	NULL
COLO	NULL
&	NULL
's	NULL
``	NULL
X	NULL
o	NULL
is	NULL
F	NULL
(	NULL
€	NULL
i2	NULL
r	NULL
‘	NULL
é	NULL
‘	NULL
=d	NULL
u	NULL
®	NULL
control	NULL
+	NULL
p38	NULL
MAP	NULL
inhibitor	NULL
Condition	NULL
IL-12/IL-2	NULL
SYNERGISM	NULL
INVOLVES	NULL
p38	NULL
MAP	NULL
KINASE/STAT	NULL
ACTIVATION	NULL
5000	NULL
4000	NULL
2000	NULL
-|	NULL
D	NULL
control	NULL
|	NULL
B	NULL
pss	NULL
aP	NULL
inhibitor	NULL
2000	NULL
DMSO	NULL
1000	NULL
l	NULL
_	NULL
IL-12	NULL
IL-2	NULL
0	NULL
IL42	NULL
+	NULL
IL-2	NULL
D	NULL
none	NULL
I	NULL
1	NULL
IL-2	NULL
IL-12	NULL
+	NULL
IL-2	NULL
control	NULL
+	NULL
p38	NULL
MAP	NULL
inhibitor	NULL
FIGURE	NULL
7	NULL
.	NULL

Inhibition	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
abrogates	NULL
T	NULL
cell	NULL
proliferation	NULL
and	NULL
IFN-y	NULL
production	NULL
induced	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
but	NULL
only	NULL
partially	NULL
blocks	NULL
cytolytic	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
Sorted	NULL
CD8	NULL
*	NULL
CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
IL-12	NULL
,	NULL
IL-2	NULL
,	NULL
or	NULL
IL-12	NULL
and	NULL
IL-2	NULL
in	NULL
96-h	NULL
proliferation	NULL
assays	NULL
or	NULL
72-h	NULL
IFN-y	NULL
assays	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
10	NULL
uM	NULL
$	NULL
B203580	NULL
in	NULL
DMSO	NULL
or	NULL
DMSO	NULL
alone	NULL
was	NULL
present	NULL
along	NULL
with	NULL
the	NULL
indicated	NULL
cytokines	NULL
for	NULL
the	NULL
entire	NULL
incubation	NULL
period	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
Sorted	NULL
CD8*CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
**	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
overnight	NULL
with	NULL
medium	NULL
alone	NULL
or	NULL
the	NULL
indicated	NULL
cytokines	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
$	NULL
B203580	NULL
.	NULL

*'Cr-labeled	NULL
COLO	NULL
or	NULL
OKT3	NULL
target	NULL
cells	NULL
were	NULL
then	NULL
added	NULL
at	NULL
a	NULL
5:1	NULL
E	NULL
:	NULL
T	NULL
cell	NULL
ratio	NULL
,	NULL
and	NULL
4-h	NULL
cytotoxicity	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
separate	NULL
experiments	NULL
.	NULL

Discussion	NULL
To	NULL
gain	NULL
insight	NULL
into	NULL
the	NULL
mechanism	NULL
underlying	NULL
the	NULL
synergistic	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
we	NULL
have	NULL
examined	NULL
two	NULL
of	NULL
the	NULL
signaling	NULL
pathways	NULL
activated	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

Rather	NULL
than	NULL
using	NULL
T	NULL
cell	NULL
lines	NULL
or	NULL
T	NULL
cells	NULL
activated	NULL
in	NULL
vitro	NULL
with	NULL
mitogens	NULL
or	NULL
CD3	NULL
cross-linking	NULL
to	NULL
analyze	NULL
the	NULL
signaling	NULL
pathways	NULL
activated	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
we	NULL
have	NULL
focused	NULL
on	NULL
two	NULL
subsets	NULL
of	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
that	NULL
differ	NULL
dramatically	NULL
in	NULL
their	NULL
intrinsic	NULL
ability	NULL
to	NULL
respond	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

This	NULL
not	NULL
only	NULL
allows	NULL
for	NULL
the	NULL
analysis	NULL
of	NULL
cytokine-activated	NULL
signaling	NULL
pathways	NULL
and	NULL
functional	NULL
responses	NULL
unperturbed	NULL
by	NULL
prior	NULL
in	NULL
vitro	NULL
ma-nipulation	NULL
,	NULL
but	NULL
also	NULL
adds	NULL
a	NULL
component	NULL
of	NULL
physiologic	NULL
relevance	NULL
to	NULL
the	NULL
signaling	NULL
pathways	NULL
being	NULL
studied	NULL
,	NULL
as	NULL
the	NULL
cytokine-induced	NULL
activation	NULL
of	NULL
CD8	NULL
T	NULL
cells	NULL
may	NULL
be	NULL
critical	NULL
to	NULL
the	NULL
host	NULL
response	NULL
to	NULL
both	NULL
infectious	NULL
pathogens	NULL
and	NULL
tumors	NULL
(	NULL
37	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Within	NULL
both	NULL
the	NULL
JAK/STAT	NULL
and	NULL
MAP	NULL
kinase	NULL
family	NULL
signaling	NULL
pathways	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
IL-12	NULL
and	NULL
IL-2	NULL
together	NULL
synergistically	NULL
increase	NULL
the	NULL
activation	NULL
of	NULL
signaling	NULL
proteins	NULL
in	NULL
CD8	NULL
*CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
a	NULL
manner	NULL
that	NULL
correlates	NULL
with	NULL
the	NULL
augmentation	NULL
of	NULL
T	NULL
cell	NULL
proliferation	NULL
,	NULL
IFN-y	NULL
production	NULL
,	NULL
and	NULL
cytolytic	NULL
activity	NULL
.	NULL

Specifically	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
T	NULL
cell	NULL
stimulation	NULL
with	NULL
IL-12	NULL
and	NULL
IL-2	NULL
is	NULL
required	NULL
to	NULL
maximally	NULL
activate	NULL
the	NULL
stress-activated	NULL
MAP	NULL
kinases	NULL
,	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
SAPK/	NULL
JNK	NULL
,	NULL
whereas	NULL
this	NULL
same	NULL
cytokine	NULL
combination	NULL
does	NULL
not	NULL
activate	NULL
the	NULL
ERKs	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
stimulation	NULL
with	NULL
IL-12	NULL
and	NULL
IL-2	NULL
is	NULL
required	NULL
for	NULL
optimal	NULL
STAT1	NULL
and	NULL
STAT3	NULL
serine	NULL
phos-	NULL
phorylation	NULL
,	NULL
but	NULL
does	NULL
not	NULL
further	NULL
augment	NULL
STAT1	NULL
and	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
over	NULL
the	NULL
level	NULL
observed	NULL
in	NULL
response	NULL
to	NULL
either	NULL
cytokine	NULL
alone	NULL
.	NULL

Finally	NULL
,	NULL
through	NULL
the	NULL
use	NULL
of	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
to	NULL
augment	NULL
functional	NULL
responses	NULL
and	NULL
STAT1	NULL
and	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
in	NULL
CD8	NULL
*CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
is	NULL
p38	NULL
MAP	NULL
kinase	NULL
dependent	NULL
.	NULL

While	NULL
ERK	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
and	NULL
IL-12	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
murine	NULL
cell	NULL
lines	NULL
and	NULL
in	NULL
mitogen-activated	NULL
murine	NULL
and	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
CD8	NULL
``	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
subset	NULL
of	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
expressing	NULL
IL-12	NULL
and	NULL
IL-2	NULL
receptors	NULL
did	NULL
not	NULL
display	NULL
activation	NULL
of	NULL
ERK1	NULL
or	NULL
ERK2	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
with	NULL
IL-12	NULL
and/or	NULL
IL-2	NULL
.	NULL

This	NULL
was	NULL
not	NULL
due	NULL
to	NULL
a	NULL
defect	NULL
in	NULL
the	NULL
ERK	NULL
signaling	NULL
pathway	NULL
,	NULL
as	NULL
PMA	NULL
was	NULL
able	NULL
to	NULL
activate	NULL
ERK2	NULL
in	NULL
the	NULL
same	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

Although	NULL
the	NULL
ERKs	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
IL-12	NULL
and	NULL
IL-2	NULL
responsiveness	NULL
in	NULL
T	NULL
cell	NULL
lines	NULL
or	NULL
in	NULL
mitogen-	NULL
or	NULL
CD3-activated	NULL
T	NULL
cells	NULL
,	NULL
they	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
have	NULL
a	NULL
role	NULL
in	NULL
the	NULL
TCR-independent	NULL
activation	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
CD8	NULL
*CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
stress	NULL
kinases	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
correlated	NULL
well	NULL
with	NULL
the	NULL
functional	NULL
synergy	NULL
between	NULL
these	NULL
cytokines	NULL
in	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

Since	NULL
the	NULL
activation	NULL
of	NULL
both	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
SAPK/JINK	NULL
was	NULL
greatly	NULL
augmented	NULL
in	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
both	NULL
kinases	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
functional	NULL
responsiveness	NULL
to	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

However	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
proliferation	NULL
,	NULL
IFN-y	NULL
production	NULL
,	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
non-MHC-restricted	NULL
cytolytic	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
p38	NULL
MAP	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
kinase	NULL
inhibitor	NULL
is	NULL
strong	NULL
evidence	NULL
that	NULL
p38	NULL
MAP	NULL
kinase	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
response	NULL
of	NULL
CD8	NULL
*CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
to	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
p38	NULL
MAP	NULL
kinase	NULL
,	NULL
but	NULL
not	NULL
SAPK/JNK	NULL
or	NULL
ERK1/	NULL
ERK2	NULL
,	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
weakly	NULL
expressed	NULL
in	NULL
CD18	NULL
``	NULL
T	NULL
cells	NULL
(	NULL
two	NULL
peripheral	NULL
blood	NULL
T	NULL
cell	NULL
subsets	NULL
that	NULL
are	NULL
responsive	NULL
and	NULL
unresponsive	NULL
,	NULL
respectively	NULL
,	NULL
to	NULL
the	NULL
IL-12	NULL
and	NULL
IL-2	NULL
combination	NULL
)	NULL
lends	NULL
further	NULL
support	NULL
to	NULL
the	NULL
hypothesis	NULL
that	NULL
p38	NULL
MAP	NULL
kinase	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
mediating	NULL
the	NULL
functional	NULL
synergy	NULL
between	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
examining	NULL
T	NULL
cell	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
also	NULL
found	NULL
that	NULL
although	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
SAPK/JNK	NULL
are	NULL
both	NULL
activated	NULL
by	NULL
IL-2	NULL
,	NULL
proliferation	NULL
could	NULL
be	NULL
inhibited	NULL
with	NULL
a	NULL
p38	NULL
MAP	NULL
kinase	NULL
inhibitor	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Nonetheless	NULL
,	NULL
it	NULL
is	NULL
still	NULL
possible	NULL
that	NULL
p38	NULL
MAP	NULL
kinase	NULL
activation	NULL
is	NULL
necessary	NULL
,	NULL
but	NULL
not	NULL
suffi-cient	NULL
,	NULL
for	NULL
mediating	NULL
the	NULL
functional	NULL
effects	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
and	NULL
SAPK/JNK	NULL
activation	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
conjunction	NULL
with	NULL
p38	NULL
MAP	NULL
kinase	NULL
.	NULL

A	NULL
recent	NULL
report	NULL
demonstrated	NULL
that	NULL
p38	NULL
MAP	NULL
kinase	NULL
activation	NULL
is	NULL
required	NULL
for	NULL
mitogen-induced	NULL
IFN-y	NULL
production	NULL
in	NULL
CD4	NULL
*	NULL
Th1	NULL
cells	NULL
(	NULL
45	NULL
)	NULL
.	NULL

In	NULL
that	NULL
study	NULL
1-10	NULL
uM	NULL
SB203580	NULL
had	NULL
a	NULL
profound	NULL
effect	NULL
on	NULL
Th1	NULL
cell	NULL
IFN-y	NULL
production	NULL
in	NULL
response	NULL
to	NULL
Con	NULL
A	NULL
without	NULL
affecting	NULL
IL-4	NULL
production	NULL
by	NULL
Th2	NULL
cells	NULL
.	NULL

A	NULL
dominant	NULL
negative	NULL
form	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
had	NULL
the	NULL
same	NULL
inhibitory	NULL
effect	NULL
on	NULL
IFN-y	NULL
production	NULL
,	NULL
whereas	NULL
a	NULL
dominant	NULL
negative	NULL
form	NULL
of	NULL
JNK	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

Those	NULL
findings	NULL
support	NULL
our	NULL
observation	NULL
that	NULL
p38	NULL
MAP	NULL
kinase	NULL
,	NULL
rather	NULL
than	NULL
SAPK/JNK	NULL
,	NULL
is	NULL
a	NULL
key	NULL
regulator	NULL
of	NULL
cytokine-induced	NULL
IFN-y	NULL
production	NULL
in	NULL
CD8	NULL
``	NULL
CD18°	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

As	NULL
IL-12	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
Th1	NULL
cell	NULL
development	NULL
and	NULL
,	NULL
along	NULL
with	NULL
IL-2	NULL
,	NULL
is	NULL
a	NULL
potent	NULL
stimulator	NULL
of	NULL
IFN-y	NULL
production	NULL
by	NULL
Th1	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
probable	NULL
that	NULL
p38	NULL
MAP	NULL
kinase	NULL
activation	NULL
is	NULL
critical	NULL
to	NULL
both	NULL
CD4	NULL
*	NULL
and	NULL
CD8	NULL
*	NULL
T	NULL
cell	NULL
IL-12/IL-2	NULL
responsiveness	NULL
.	NULL

As	NULL
a	NULL
parallel	NULL
to	NULL
our	NULL
findings	NULL
with	NULL
CD18®	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
observed	NULL
that	NULL
IL-12	NULL
and	NULL
IL-2	NULL
can	NULL
also	NULL
activate	NULL
p38	NULL
MAP	NULL
kinase	NULL
in	NULL
NK	NULL
cells	NULL
,	NULL
a	NULL
lymphocyte	NULL
subset	NULL
that	NULL
bears	NULL
a	NULL
striking	NULL
immunophenotypic	NULL
and	NULL
functional	NULL
resemblance	NULL
to	NULL
CD8	NULL
T	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
functional	NULL
response	NULL
of	NULL
NK	NULL
cells	NULL
to	NULL
IL-12	NULL
and/or	NULL
IL-2	NULL
is	NULL
inhibited	NULL
by	NULL
$	NULL
B203580	NULL
(	NULL
J	NULL
.	NULL

A.	NULL
G.	NULL
and	NULL
D.	NULL
A.	NULL
F.	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
responses	NULL
of	NULL
peripheral	NULL
blood	NULL
NK	NULL
cells	NULL
and	NULL
CD8	NULL
*CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
to	NULL
Th1	NULL
type	NULL
cytokines	NULL
are	NULL
p38	NULL
MAP	NULL
kinase	NULL
dependent	NULL
.	NULL

Whereas	NULL
STAT	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
or	NULL
IL-2	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
CD18	NULL
``	NULL
T	NULL
cells	NULL
weakly	NULL
expressing	NULL
IL-12	NULL
and	NULL
IL-2	NULL
receptors	NULL
,	NULL
the	NULL
tyrosine	NULL
and	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STATs	NULL
was	NULL
seen	NULL
in	NULL
CD18	NULL
``	NULL
``	NULL
®**	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
both	NULL
cytokines	NULL
.	NULL

However	NULL
,	NULL
the	NULL
functional	NULL
synergy	NULL
between	NULL
IL-12	NULL
and	NULL
IL-2	NULL
correlated	NULL
not	NULL
with	NULL
STAT	NULL
tyrosine	NULL
phosphorylation	NULL
but	NULL
,	NULL
rather	NULL
,	NULL
with	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
.	NULL

One	NULL
explanation	NULL
for	NULL
this	NULL
finding	NULL
is	NULL
that	NULL
the	NULL
small	NULL
amount	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
induced	NULL
by	NULL
IL-12	NULL
or	NULL
IL-2	NULL
alone	NULL
in	NULL
CD8	NULL
*CD18°	NULL
``	NULL
***	NULL
T	NULL
cells	NULL
is	NULL
insufficient	NULL
to	NULL
mediate	NULL
gene	NULL
activation	NULL
in	NULL
and	NULL
of	NULL
itself	NULL
.	NULL

Only	NULL
when	NULL
STAT1	NULL
and	NULL
STAT3	NULL
contain	NULL
the	NULL
additional	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
,	NULL
as	NULL
occurs	NULL
following	NULL
treatment	NULL
with	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
can	NULL
the	NULL
necessary	NULL
gene	NULL
activation	NULL
occur	NULL
that	NULL
results	NULL
in	NULL
the	NULL
functional	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
serine	NULL
phosphorylation	NULL
in	NULL
the	NULL
function	NULL
of	NULL
STATs	NULL
has	NULL
been	NULL
demonstrated	NULL
at	NULL
the	NULL
level	NULL
of	NULL
DNA	NULL
binding	NULL
and	NULL
gene	NULL
transcription	NULL
.	NULL

While	NULL
STAT	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
critical	NULL
for	NULL
STAT	NULL
dimerization	NULL
,	NULL
nuclear	NULL
translocation	NULL
,	NULL
and	NULL
DNA	NULL
bind-ing	NULL
,	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
STAT3-STAT3	NULL
homodimers	NULL
to	NULL
DNA	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Serine	NULL
phosphorylation	NULL
is	NULL
also	NULL
necessary	NULL
for	NULL
maximal	NULL
transcriptional	NULL
activation	NULL
by	NULL
tyrosine-phosphorylated	NULL
STAT1	NULL
and	NULL
STAT3	NULL
(	NULL
27	NULL
)	NULL
.	NULL

A	NULL
recent	NULL
report	NULL
(	NULL
46	NULL
)	NULL
demonstrated	NULL
that	NULL
STAT	NULL
transcriptional	NULL
activation	NULL
by	NULL
IFN-y	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
,	NULL
and	NULL
that	NULL
this	NULL
serine	NULL
phosphorylation	NULL
is	NULL
required	NULL
for	NULL
the	NULL
interaction	NULL
of	NULL
STAT1	NULL
a	NULL
with	NULL
MCMS	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
minichromosome	NULL
maintenance	NULL
(	NULL
MCM	NULL
)	NULL
family	NULL
involved	NULL
in	NULL
DNA	NULL
replication	NULL
.	NULL

4479	NULL
In	NULL
addition	NULL
to	NULL
STAT1	NULL
and	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
,	NULL
the	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STATS	NULL
may	NULL
also	NULL
be	NULL
important	NULL
in	NULL
enhancing	NULL
STATS5-mediated	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
IL-2	NULL
and	NULL
IL-12	NULL
.	NULL

Although	NULL
we	NULL
do	NULL
not	NULL
have	NULL
Abs	NULL
that	NULL
specifically	NULL
recognize	NULL
the	NULL
serine-phosphorylated	NULL
form	NULL
of	NULL
STAT5	NULL
,	NULL
it	NULL
is	NULL
known	NULL
that	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STATS	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
is	NULL
accompanied	NULL
by	NULL
serine	NULL
phosphorylation	NULL
(	NULL
29	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
seen	NULL
after	NULL
IL-12	NULL
and	NULL
IL-2	NULL
treatment	NULL
in	NULL
CD8	NULL
~CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
may	NULL
occur	NULL
in	NULL
STATS	NULL
as	NULL
well	NULL
.	NULL

Despite	NULL
the	NULL
prominent	NULL
STATS	NULL
tyrosine	NULL
phosphorylation	NULL
relative	NULL
to	NULL
STAT1	NULL
and	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
seen	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
alone	NULL
in	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
serine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
combined	NULL
stimulation	NULL
with	NULL
IL-12	NULL
and	NULL
IL-2	NULL
might	NULL
still	NULL
be	NULL
capable	NULL
of	NULL
further	NULL
augmenting	NULL
STAT5-mediated	NULL
transcriptional	NULL
activation	NULL
.	NULL

It	NULL
is	NULL
intriguing	NULL
that	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
and	NULL
IL-2	NULL
is	NULL
completely	NULL
abolished	NULL
by	NULL
an	NULL
inhibitor	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
,	NULL
for	NULL
it	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
STAT1	NULL
and	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
in	NULL
CD18	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
is	NULL
either	NULL
directly	NULL
or	NULL
indirectly	NULL
mediated	NULL
by	NULL
p38	NULL
MAP	NULL
kinase	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
this	NULL
is	NULL
the	NULL
first	NULL
evidence	NULL
in	NULL
lymphocytes	NULL
that	NULL
the	NULL
JAK/STAT	NULL
and	NULL
MAP	NULL
kinase	NULL
family	NULL
signaling	NULL
pathways	NULL
may	NULL
interact	NULL
at	NULL
the	NULL
level	NULL
of	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
,	NULL
and	NULL
that	NULL
this	NULL
interaction	NULL
may	NULL
be	NULL
necessary	NULL
to	NULL
maximize	NULL
the	NULL
functional	NULL
response	NULL
to	NULL
Thl-type	NULL
cytokines	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
$	NULL
B203580	NULL
inhibits	NULL
both	NULL
STAT1	NULL
and	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
and	NULL
the	NULL
functional	NULL
response	NULL
to	NULL
IL-12	NULL
and	NULL
IL-2	NULL
without	NULL
affecting	NULL
STAT	NULL
tyrosine	NULL
phosphorylation	NULL
further	NULL
suggests	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
may	NULL
be	NULL
necessary	NULL
,	NULL
but	NULL
not	NULL
suf-ficient	NULL
,	NULL
for	NULL
STATs	NULL
to	NULL
mediate	NULL
the	NULL
functional	NULL
effects	NULL
of	NULL
the	NULL
IL-12/	NULL
IL-2	NULL
combination	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
,	NULL
however	NULL
,	NULL
that	NULL
if	NULL
STAT1	NULL
and	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
is	NULL
occurring	NULL
via	NULL
p38	NULL
MAP	NULL
kinase	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
this	NULL
is	NULL
not	NULL
responsible	NULL
for	NULL
the	NULL
functional	NULL
synergy	NULL
between	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

Instead	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
other	NULL
known	NULL
substrates	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
,	NULL
such	NULL
as	NULL
ATF-2	NULL
,	NULL
heat	NULL
shock	NULL
protein	NULL
27	NULL
,	NULL
or	NULL
MAP	NULL
kinase	NULL
activating	NULL
protein	NULL
kinase-2	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
,	NULL
may	NULL
be	NULL
contributing	NULL
to	NULL
that	NULL
effect	NULL
.	NULL

Furthermore	NULL
,	NULL
if	NULL
p38	NULL
MAP	NULL
kinase	NULL
is	NULL
responsible	NULL
for	NULL
STAT1	NULL
and	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
it	NULL
may	NULL
not	NULL
be	NULL
responsible	NULL
for	NULL
cytokine-induced	NULL
STATS	NULL
serine	NULL
phosphorylation	NULL
,	NULL
as	NULL
STAT5a	NULL
and	NULL
STAT5b	NULL
lack	NULL
the	NULL
-Pro-X-Ser-Pro-	NULL
MAP	NULL
kinase	NULL
phosphorylation	NULL
motif	NULL
(	NULL
49	NULL
)	NULL
shared	NULL
by	NULL
STAT1	NULL
and	NULL
STAT3	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

This	NULL
MAP	NULL
kinase	NULL
phosphorylation	NULL
motif	NULL
is	NULL
also	NULL
shared	NULL
by	NULL
STAT4	NULL
,	NULL
and	NULL
as	NULL
STAT4	NULL
is	NULL
activated	NULL
by	NULL
IL-12	NULL
and	NULL
is	NULL
necessary	NULL
for	NULL
lymphocyte	NULL
IL-12	NULL
responsiveness	NULL
(	NULL
24	NULL
)	NULL
,	NULL
it	NULL
will	NULL
be	NULL
important	NULL
to	NULL
determine	NULL
whether	NULL
STAT4	NULL
serine	NULL
phosphorylation	NULL
is	NULL
also	NULL
augmented	NULL
through	NULL
stimulation	NULL
with	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
S	NULL
$	NULL
B203580	NULL
alone	NULL
,	NULL
there	NULL
is	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
in	NULL
unstimulated	NULL
CD18°	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
its	NULL
ability	NULL
to	NULL
inhibit	NULL
the	NULL
activity	NULL
of	NULL
phosphorylated	NULL
p38	NULL
MAP	NULL
kinase	NULL
,	NULL
SB203580	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
the	NULL
activity	NULL
of	NULL
MKK6	NULL
(	NULL
44	NULL
)	NULL
.	NULL

While	NULL
MKK6	NULL
is	NULL
one	NULL
of	NULL
the	NULL
major	NULL
upstream	NULL
activators	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
,	NULL
it	NULL
does	NULL
not	NULL
activate	NULL
SAPK/JNK	NULL
.	NULL

In	NULL
unstimulated	NULL
CD8	NULL
``	NULL
CD18	NULL
``	NULL
``	NULL
®	NULL
``	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
therefore	NULL
,	NULL
the	NULL
heightened	NULL
level	NULL
of	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
induced	NULL
by	NULL
SB203580	NULL
may	NULL
in	NULL
part	NULL
be	NULL
due	NULL
to	NULL
the	NULL
MKK6-induced	NULL
activation	NULL
of	NULL
an	NULL
unidentified	NULL
serine/	NULL
threonine	NULL
kinase	NULL
distinct	NULL
from	NULL
p38	NULL
MAP	NULL
kinase	NULL
that	NULL
is	NULL
not	NULL
inhibited	NULL
by	NULL
$	NULL
B203580	NULL
.	NULL

While	NULL
we	NULL
observed	NULL
that	NULL
SB203580-treated	NULL
cells	NULL
were	NULL
unable	NULL
to	NULL
mediate	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
we	NULL
also	NULL
found	NULL
that	NULL
stimulation	NULL
with	NULL
IL-12	NULL
and	NULL
IL-2	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
activity	NULL
abrogated	NULL
the	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4480	NULL
heightened	NULL
basal	NULL
levels	NULL
of	NULL
serine-phosphorylated	NULL
STAT	NULL
's	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
concomitant	NULL
signaling	NULL
through	NULL
both	NULL
IL-12	NULL
and	NULL
IL-2	NULL
receptors	NULL
may	NULL
activate	NULL
a	NULL
STAT	NULL
serine	NULL
phosphatase	NULL
that	NULL
normally	NULL
serves	NULL
to	NULL
limit	NULL
the	NULL
duration	NULL
of	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
following	NULL
augmentation	NULL
of	NULL
the	NULL
serine	NULL
kinase	NULL
activity	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

When	NULL
this	NULL
putative	NULL
serine	NULL
phosphatase	NULL
is	NULL
activated	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
$	NULL
B203580	NULL
,	NULL
the	NULL
phosphatase	NULL
activity	NULL
may	NULL
predominate	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
activity	NULL
,	NULL
thereby	NULL
favoring	NULL
the	NULL
loss	NULL
of	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
.	NULL

The	NULL
ability	NULL
to	NULL
correlate	NULL
the	NULL
functional	NULL
synergy	NULL
between	NULL
IL-12	NULL
and	NULL
IL-2	NULL
with	NULL
synergy	NULL
observed	NULL
at	NULL
the	NULL
level	NULL
of	NULL
signal	NULL
transduction	NULL
provides	NULL
a	NULL
basis	NULL
for	NULL
understanding	NULL
which	NULL
signaling	NULL
pathways	NULL
mediate	NULL
select	NULL
functional	NULL
responses	NULL
to	NULL
these	NULL
cytokines	NULL
in	NULL
lymphocytes	NULL
.	NULL

Our	NULL
findings	NULL
suggest	NULL
that	NULL
T	NULL
cell	NULL
proliferation	NULL
and	NULL
IFN-y	NULL
production	NULL
induced	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
are	NULL
regulated	NULL
through	NULL
p38	NULL
MAP	NULL
kinase	NULL
activation	NULL
,	NULL
although	NULL
SAPK/JNK	NULL
activation	NULL
may	NULL
play	NULL
a	NULL
role	NULL
as	NULL
well	NULL
.	NULL

Cytolytic	NULL
activity	NULL
induced	NULL
by	NULL
these	NULL
cytokines	NULL
,	NULL
especially	NULL
CD3-activated	NULL
cytotoxicity	NULL
,	NULL
appeared	NULL
to	NULL
be	NULL
less	NULL
affected	NULL
by	NULL
inhibition	NULL
of	NULL
p38	NULL
MAP	NULL
kinase	NULL
activity	NULL
and	NULL
may	NULL
therefore	NULL
be	NULL
regulated	NULL
by	NULL
a	NULL
different	NULL
signaling	NULL
pathway	NULL
.	NULL

Although	NULL
we	NULL
have	NULL
observed	NULL
a	NULL
strong	NULL
association	NULL
between	NULL
p38	NULL
MAP	NULL
kinase	NULL
activation	NULL
and	NULL
STAT1	NULL
and	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
,	NULL
additional	NULL
studies	NULL
will	NULL
be	NULL
required	NULL
to	NULL
prove	NULL
that	NULL
STAT1	NULL
and	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
are	NULL
indeed	NULL
mediated	NULL
by	NULL
p38	NULL
MAP	NULL
kinase	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
detailed	NULL
analysis	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
on	NULL
IL-12	NULL
and	NULL
IL-2-induced	NULL
gene	NULL
transcription	NULL
will	NULL
be	NULL
necessary	NULL
to	NULL
more	NULL
cogently	NULL
establish	NULL
the	NULL
role	NULL
of	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
in	NULL
the	NULL
functional	NULL
synergy	NULL
between	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
John	NULL
Daley	NULL
and	NULL
Suzan	NULL
Lazo	NULL
for	NULL
their	NULL
expert	NULL
assistance	NULL
with	NULL
cell	NULL
sorting	NULL
and	NULL
FACS	NULL
analysis	NULL
.	NULL

We	NULL
thank	NULL
Genetics	NULL
Institute	NULL
for	NULL
generously	NULL
providing	NULL
human	NULL
rIL-12	NULL
,	NULL
and	NULL
SmithKline	NULL
Beecham	NULL
for	NULL
generously	NULL
providing	NULL
the	NULL
p38	NULL
MAP	NULL
kinase	NULL
inhibitor	NULL
(	NULL
SB203580	NULL
)	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Kobayashi	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Fitz	NULL
,	NULL
M.	NULL
Ryan	NULL
,	NULL
R.	NULL
Hewick	NULL
,	NULL
S.	NULL
Clark	NULL
,	NULL
S.	NULL
Chan	NULL
,	NULL
R.	NULL
Loudon	NULL
,	NULL
F.	NULL
Sherman	NULL
,	NULL
B.	NULL
Perussia	NULL
,	NULL
and	NULL
G.	NULL
Trinchieri	NULL
.	NULL

1989	NULL
.	NULL

Identification	NULL
and	NULL
purification	NULL
of	NULL
natural	NULL
killer	NULL
cell	NULL
stimulatory	NULL
factor	NULL
(	NULL
NKSF	NULL
)	NULL
,	NULL
a	NULL
cytokine	NULL
with	NULL
multiple	NULL
biologic	NULL
effects	NULL
on	NULL
human	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170:827	NULL
.	NULL

2	NULL
.	NULL

Chua	NULL
,	NULL
A.	NULL
O.	NULL
,	NULL
R.	NULL
Chizzonite	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
Desai	NULL
,	NULL
T.	NULL
P.	NULL
Truitt	NULL
,	NULL
P.	NULL
Nunes	NULL
,	NULL
L.	NULL
J.	NULL
Minetti	NULL
,	NULL
R.	NULL
R.	NULL
Warrier	NULL
,	NULL
D.	NULL
H.	NULL
Presky	NULL
,	NULL
J.	NULL
F.	NULL
Levine	NULL
,	NULL
M.	NULL
K.	NULL
Gately	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Expression	NULL
cloning	NULL
of	NULL
a	NULL
human	NULL
IL-12	NULL
receptor	NULL
component	NULL
:	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
cytokine	NULL
receptor	NULL
superfamily	NULL
with	NULL
strong	NULL
homology	NULL
to	NULL
gp130	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:128	NULL
.	NULL

3	NULL
.	NULL

Desai	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
P.	NULL
M.	NULL
Quinn	NULL
,	NULL
A.	NULL
G.	NULL
Wolitzky	NULL
,	NULL
P.	NULL
K.	NULL
A.	NULL
Mongini	NULL
,	NULL
R.	NULL
Chizzonite	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Gately	NULL
.	NULL

1992	NULL
.	NULL

IL-12	NULL
receptor	NULL
.	NULL

II	NULL
.	NULL

Distribution	NULL
and	NULL
regulation	NULL
of	NULL
receptor	NULL
expression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:3125	NULL
.	NULL

4	NULL
.	NULL

Presky	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
H.	NULL
Yang	NULL
,	NULL
L.	NULL
J.	NULL
Minetti	NULL
,	NULL
A.	NULL
O.	NULL
Chua	NULL
,	NULL
N.	NULL
Nabavi	NULL
,	NULL
C.-Y	NULL
.	NULL

Wu	NULL
,	NULL
M.	NULL
K.	NULL
Gately	NULL
,	NULL
and	NULL
U.	NULL
Gubler	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
functional	NULL
interleukin	NULL
12	NULL
receptor	NULL
complex	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
$	NULL
type	NULL
cytokine	NULL
receptor	NULL
subunits	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:14002	NULL
.	NULL

5	NULL
.	NULL

Wu	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
R.	NULL
R.	NULL
Warrier	NULL
,	NULL
X.	NULL
Wang	NULL
,	NULL
D.	NULL
H.	NULL
Presky	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Gately	NULL
.	NULL

1997	NULL
.	NULL

Regulation	NULL
of	NULL
interleukin-12	NULL
receptor	NULL
B1	NULL
chain	NULL
expression	NULL
and	NULL
interleukin-12	NULL
binding	NULL
by	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27	NULL
:	NULL
147	NULL
.	NULL

6	NULL
.	NULL

Mehrotra	NULL
,	NULL
P.	NULL
T.	NULL
,	NULL
D.	NULL
Wu	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Crim	NULL
,	NULL
H.	NULL
S.	NULL
Mostowski	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Siegel	NULL
.	NULL

1993	NULL
.	NULL

Effects	NULL
of	NULL
IL-12	NULL
on	NULL
the	NULL
generation	NULL
of	NULL
cytotoxic	NULL
activity	NULL
in	NULL
human	NULL
CD8*	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:2444	NULL
.	NULL

7	NULL
.	NULL

Gollob	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
Li	NULL
,	NULL
E.	NULL
L.	NULL
Reinherz	NULL
,	NULL
and	NULL
J.	NULL
Ritz	NULL
.	NULL

1995	NULL
.	NULL

CD2	NULL
regulates	NULL
responsiveness	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
to	NULL
interleukin	NULL
12	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:721	NULL
.	NULL

8	NULL
.	NULL

Perussia	NULL
,	NULL
B.	NULL
,	NULL
S.	NULL
H.	NULL
Chan	NULL
,	NULL
A	NULL
.	NULL

D'Andrea	NULL
,	NULL
K.	NULL
Tsuji	NULL
,	NULL
D.	NULL
Santoli	NULL
,	NULL
M.	NULL
Pospisil	NULL
,	NULL
D.	NULL
Young	NULL
,	NULL
S.	NULL
F.	NULL
Wolf	NULL
,	NULL
and	NULL
G.	NULL
Trinchieri	NULL
.	NULL

1992	NULL
.	NULL

Natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cell	NULL
stimulatory	NULL
factor	NULL
or	NULL
IL-12	NULL
has	NULL
differential	NULL
effects	NULL
on	NULL
the	NULL
proliferation	NULL
of	NULL
TCR-af*	NULL
,	NULL
TCR-y8*	NULL
T	NULL
lymphocytes	NULL
,	NULL
and	NULL
NK	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:3495	NULL
.	NULL

9	NULL
.	NULL

Chan	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
B.	NULL
Perussia	NULL
,	NULL
J.	NULL
W.	NULL
Gupta	NULL
,	NULL
M.	NULL
Kobayashi	NULL
,	NULL
M.	NULL
Pospisil	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
S.	NULL
W.	NULL
Wolf	NULL
,	NULL
D.	NULL
Young	NULL
,	NULL
S.	NULL
C.	NULL
Clark	NULL
,	NULL
and	NULL
G.	NULL
Trinchieri	NULL
.	NULL

1991	NULL
.	NULL

Induction	NULL
of	NULL
interferon-y	NULL
production	NULL
by	NULL
natural	NULL
killer	NULL
cell	NULL
stimulatory	NULL
factor	NULL
:	NULL
characterization	NULL
of	NULL
responder	NULL
cells	NULL
and	NULL
synergy	NULL
with	NULL
other	NULL
inducers	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:869	NULL
.	NULL

10	NULL
.	NULL

Gately	NULL
,	NULL
M.	NULL
,	NULL
B.	NULL
Desai	NULL
,	NULL
A.	NULL
Wolitzky	NULL
,	NULL
P.	NULL
Quinn	NULL
,	NULL
C.	NULL
Dwyer	NULL
,	NULL
F.	NULL
Podalski	NULL
,	NULL
P.	NULL
Familletti	NULL
,	NULL
F.	NULL
Sinigaglia	NULL
,	NULL
R.	NULL
Chizonnite	NULL
,	NULL
U.	NULL
Gubler	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1991	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
lymphocyte	NULL
proliferation	NULL
by	NULL
a	NULL
hetrodimeric	NULL
cytokine	NULL
,	NULL
IL-12	NULL
(	NULL
cytotoxic	NULL
lymphocyte	NULL
maturation	NULL
factor	NULL
)	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:874	NULL
.	NULL

IL-12/IL-2	NULL
SYNERGISM	NULL
INVOLVES	NULL
p38	NULL
MAP	NULL
KINASE/STAT	NULL
ACTIVATION	NULL
11	NULL
.	NULL

Robertson	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
R.	NULL
J.	NULL
Soiffer	NULL
,	NULL
S.	NULL
F.	NULL
Wolf	NULL
,	NULL
T.	NULL
J.	NULL
Manley	NULL
,	NULL
C.	NULL
Donahue	NULL
,	NULL
D.	NULL
Young	NULL
,	NULL
S.	NULL
H.	NULL
Herrmann	NULL
,	NULL
and	NULL
J.	NULL
Ritz	NULL
.	NULL

1992	NULL
.	NULL

Response	NULL
of	NULL
human	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
to	NULL
NK	NULL
cell	NULL
stimulatory	NULL
factor	NULL
(	NULL
NKSPF	NULL
)	NULL
:	NULL
cytolytic	NULL
activity	NULL
and	NULL
proliferation	NULL
of	NULL
NK	NULL
cells	NULL
is	NULL
differentially	NULL
regulated	NULL
by	NULL
NKSF	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:779	NULL
.	NULL

12	NULL
.	NULL

Romagnani	NULL
,	NULL
S.	NULL
1995	NULL
.	NULL

Biology	NULL
of	NULL
human	NULL
Thi	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

15:121	NULL
.	NULL

13	NULL
.	NULL

Trinchieri	NULL
,	NULL
G.	NULL
1993	NULL
.	NULL

Interleukin-12	NULL
and	NULL
its	NULL
role	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
Th1	NULL
cells	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
14:335	NULL
.	NULL

14	NULL
.	NULL

Perkins	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
J.	NULL
Marvel	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Collins	NULL
.	NULL

1993	NULL
.	NULL

Interleukin	NULL
2	NULL
activates	NULL
extracellular	NULL
signal-regulated	NULL
protein	NULL
kinase	NULL
2	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1429	NULL
.	NULL

15	NULL
.	NULL

Watts	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
M.	NULL
J.	NULL
Welham	NULL
,	NULL
L.	NULL
Kalt	NULL
,	NULL
J.	NULL
W.	NULL
Schrader	NULL
,	NULL
and	NULL
R.	NULL
Aebersold	NULL
.	NULL

1993	NULL
.	NULL

IL-2	NULL
stimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
induces	NULL
sequential	NULL
activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
and	NULL
phosphorylation	NULL
of	NULL
p56	NULL
``	NULL
**	NULL
at	NULL
serine-59	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:6862	NULL
.	NULL

16	NULL
.	NULL

Crawley	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
L.	NULL
Rawlinson	NULL
,	NULL
F.	NULL
V.	NULL
Lali	NULL
,	NULL
T.	NULL
H.	NULL
Page	NULL
,	NULL
J.	NULL
Saklatvala	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
J.	NULL
Foxwell	NULL
.	NULL

1997	NULL
.	NULL

T	NULL
cell	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
interleukins	NULL
2	NULL
and	NULL
7	NULL
requires	NULL
p38	NULL
MAP	NULL
kinase	NULL
activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:15023	NULL
.	NULL

17	NULL
.	NULL

Pignata	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
Sanghera	NULL
,	NULL
L.	NULL
Cossette	NULL
,	NULL
S.	NULL
Pelech	NULL
,	NULL
and	NULL
J.	NULL
Ritz	NULL
.	NULL

1994	NULL
.	NULL

Interleukin-12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
44-kD	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Blood	NULL
83:184	NULL
.	NULL

18	NULL
.	NULL

Beyacrt	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
Cuenda	NULL
,	NULL
W.	NULL
V.	NULL
Berghe	NULL
,	NULL
S.	NULL
Plaisance	NULL
,	NULL
J.	NULL
C.	NULL
Lee	NULL
,	NULL
G.	NULL
Hacgeman	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
and	NULL
W.	NULL
Fiers	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
p38/RK	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
pathway	NULL
regulates	NULL
interleukin-6	NULL
synthesis	NULL
in	NULL
response	NULL
to	NULL
tumour	NULL
necrosis	NULL
factor	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:1914	NULL
.	NULL

19	NULL
.	NULL

Bacon	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
D.	NULL
W.	NULL
McVicar	NULL
,	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
,	NULL
R.	NULL
C.	NULL
Rees	NULL
,	NULL
J.	NULL
J.	NULL
O'Shea	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
12	NULL
(	NULL
IL-12	NULL
)	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
and	NULL
TYK2	NULL
:	NULL
differential	NULL
use	NULL
of	NULL
Janus	NULL
family	NULL
tyrosine	NULL
kinases	NULL
by	NULL
IL-2	NULL
and	NULL
IL-12	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:399	NULL
.	NULL

20	NULL
.	NULL

Gollob	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
E.	NULL
A.	NULL
Murphy	NULL
,	NULL
S.	NULL
Mahajan	NULL
,	NULL
C.	NULL
P.	NULL
Schnipper	NULL
,	NULL
J.	NULL
Ritz	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Frank	NULL
.	NULL

1998	NULL
.	NULL

Altered	NULL
IL-12	NULL
responsiveness	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
differential	NULL
activation	NULL
of	NULL
STATS	NULL
and	NULL
STAT1	NULL
.	NULL

Blood	NULL
91	NULL
:	NULL
1341	NULL
.	NULL

21	NULL
.	NULL

Lin	NULL
,	NULL
J.-X	NULL
.	NULL

,	NULL
T.-S.	NULL
Migone	NULL
,	NULL
M.	NULL
Tsang	NULL
,	NULL
M.	NULL
Friedmann	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Weatherbee	NULL
,	NULL
L.	NULL
Zhou	NULL
,	NULL
A.	NULL
Yamauchi	NULL
,	NULL
E.	NULL
T.	NULL
Bloom	NULL
,	NULL
J.	NULL
Mictz	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
role	NULL
of	NULL
shared	NULL
receptor	NULL
motifs	NULL
and	NULL
common	NULL
Stat	NULL
proteins	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
cytokine	NULL
pleiotropy	NULL
and	NULL
redundancy	NULL
by	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
IL-13	NULL
,	NULL
and	NULL
IL~-15	NULL
.	NULL

Immunity	NULL
2:331	NULL
.	NULL

22	NULL
.	NULL

Bacon	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
Ortaldo	NULL
,	NULL
R.	NULL
Rees	NULL
,	NULL
A.	NULL
Larner	NULL
,	NULL
J.	NULL
Johnston	NULL
,	NULL
and	NULL
J.	NULL
O'Shea	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
STAT4	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:7307	NULL
.	NULL

23	NULL
.	NULL

Jacobson	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
S.	NULL
J.	NULL
Szabo	NULL
,	NULL
R.	NULL
M.	NULL
Weber-Nordt	NULL
,	NULL
Z.	NULL
Zhong	NULL
,	NULL
R.	NULL
D.	NULL
Schreiber	NULL
,	NULL
J.	NULL
E.	NULL
Darnell	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
12	NULL
signaling	NULL
in	NULL
T	NULL
helper	NULL
type	NULL
1	NULL
(	NULL
Th1	NULL
)	NULL
cells	NULL
involves	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
Stat	NULL
)	NULL
3	NULL
and	NULL
Stat4	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:1755	NULL
.	NULL

24	NULL
.	NULL

Thierfelder	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
J.	NULL
M.	NULL
van	NULL
Deursen	NULL
,	NULL
K.	NULL
Yamamoto	NULL
,	NULL
R.	NULL
A.	NULL
Tripp	NULL
,	NULL
S.	NULL
R.	NULL
Sarawar	NULL
,	NULL
R.	NULL
T.	NULL
Carson	NULL
,	NULL
M.	NULL
Y.	NULL
Sangster	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

A.	NULL
Vignali	NULL
,	NULL
P.	NULL
C.	NULL
Doherty	NULL
,	NULL
G.	NULL
C.	NULL
Grosveld	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Requirement	NULL
for	NULL
Stat4	NULL
in	NULL
interleukin-12-mediated	NULL
responses	NULL
of	NULL
natural	NULL
killer	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
382:171	NULL
.	NULL

25	NULL
.	NULL

Nakajima	NULL
,	NULL
H.	NULL
,	NULL
X.-W.	NULL
Liu	NULL
,	NULL
A.	NULL
Wynshaw-Boris	NULL
,	NULL
L.	NULL
Rosenthal	NULL
,	NULL
K.	NULL
Imada	NULL
,	NULL
D.	NULL
Finbloom	NULL
,	NULL
L.	NULL
Hennighausen	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1997	NULL
.	NULL

An	NULL
indirect	NULL
effect	NULL
of	NULL
STATS5a	NULL
in	NULL
IL-2-induced	NULL
proliferation	NULL
:	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
STAT	NULL
5a	NULL
in	NULL
IL-2-medi-ated	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
induction	NULL
.	NULL

Immunity	NULL
7:691	NULL
.	NULL

26	NULL
.	NULL

Bunting	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Sangster	NULL
,	NULL
J.	NULL
Thie	NULL
,	NULL
and	NULL
B.	NULL
Sorrentino	NULL
.	NULL

1998	NULL
.	NULL

Restoration	NULL
of	NULL
lymphocyte	NULL
function	NULL
in	NULL
Janus	NULL
kinase	NULL
3-deficient	NULL
mice	NULL
by	NULL
retroviral-mediated	NULL
gene	NULL
transfer	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

4:58	NULL
.	NULL

27	NULL
.	NULL

Wen	NULL
,	NULL
Z.	NULL
,	NULL
Z.	NULL
Zhong	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
.	NULL

1995	NULL
.	NULL

Maximal	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
Statl	NULL
and	NULL
Stat3	NULL
requires	NULL
both	NULL
tyrosine	NULL
and	NULL
serine	NULL
phosphorylation	NULL
.	NULL

Cell	NULL
82:241	NULL
.	NULL

28	NULL
.	NULL

Zhang	NULL
,	NULL
X.	NULL
,	NULL
J.	NULL
Blenis	NULL
,	NULL
H-C.	NULL
Li	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
and	NULL
S.	NULL
Chen-Kiang	NULL
.	NULL

1995	NULL
.	NULL

Requirement	NULL
of	NULL
serine	NULL
phosphorylation	NULL
for	NULL
formation	NULL
of	NULL
STAT-promoter	NULL
complexes	NULL
.	NULL

Science	NULL
267:1990	NULL
.	NULL

29	NULL
.	NULL

Beadling	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
Ng	NULL
,	NULL
J.	NULL
W.	NULL
Babbage	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1996	NULL
.	NULL

Interleukin-2	NULL
activation	NULL
of	NULL
STATS	NULL
requires	NULL
the	NULL
convergent	NULL
action	NULL
of	NULL
tyrosine	NULL
kinases	NULL
and	NULL
a	NULL
serine/threonine	NULL
kinase	NULL
pathway	NULL
distinct	NULL
from	NULL
the	NULL
Raf1/ERK2	NULL
MAP	NULL
kinase	NULL
pathway	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:1902	NULL
.	NULL

30	NULL
.	NULL

Chung	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
Uchida	NULL
,	NULL
T.	NULL
Grammer	NULL
,	NULL
and	NULL
J.	NULL
Blenis	NULL
.	NULL

1997	NULL
.	NULL

STAT3	NULL
serine	NULL
phosphorylation	NULL
by	NULL
ERK-dependent	NULL
and	NULL
-independent	NULL
pathways	NULL
negatively	NULL
modulates	NULL
its	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:6508	NULL
.	NULL

31	NULL
.	NULL

Cho	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
C.	NULL
M.	NULL
Bacon	NULL
,	NULL
C.	NULL
Sudarshan	NULL
,	NULL
R.	NULL
C.	NULL
Rees	NULL
,	NULL
D.	NULL
Finbloom	NULL
,	NULL
R.	NULL
Pine	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
STAT4	NULL
by	NULL
IL-12	NULL
and	NULL
IFN-	NULL
@	NULL
:	NULL
evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
ligand-induced	NULL
tyrosine	NULL
and	NULL
serine	NULL
phosphorylation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:4781	NULL
.	NULL

32	NULL
.	NULL

Frank	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
S.	NULL
Mahajan	NULL
,	NULL
and	NULL
J.	NULL
Ritz	NULL
.	NULL

1997	NULL
.	NULL

B	NULL
lymphocytes	NULL
from	NULL
patients	NULL
with	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
contain	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
1	NULL
and	NULL
STAT3	NULL
constitutively	NULL
phosphorylated	NULL
on	NULL
serine	NULL
residues	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

100:3140	NULL
.	NULL

33	NULL
.	NULL

Chan	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Kobayashi	NULL
,	NULL
D.	NULL
Santoli	NULL
,	NULL
B.	NULL
Perussia	NULL
,	NULL
and	NULL
G.	NULL
Trinchieri	NULL
.	NULL

1992	NULL
.	NULL

Mechanisms	NULL
of	NULL
IFN-y	NULL
induction	NULL
by	NULL
natural	NULL
killer	NULL
cell	NULL
stimulatory	NULL
factor	NULL
(	NULL
NKSF/AL-12	NULL
)	NULL
:	NULL
role	NULL
of	NULL
transcription	NULL
and	NULL
mRNA	NULL
stability	NULL
in	NULL
the	NULL
synergistic	NULL
interaction	NULL
between	NULL
NKSF	NULL
and	NULL
IL-2	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:92	NULL
.	NULL

34	NULL
.	NULL

Abn	NULL
,	NULL
H.-J	NULL
.	NULL

,	NULL
S.	NULL
Maruo	NULL
,	NULL
M.	NULL
Tomura	NULL
,	NULL
J.	NULL
Mu	NULL
,	NULL
T.	NULL
Mamaoka	NULL
,	NULL
K.	NULL
Nakanishi	NULL
,	NULL
S.	NULL
Clark	NULL
,	NULL
M.	NULL
Kurimoto	NULL
,	NULL
H.	NULL
Okamura	NULL
,	NULL
and	NULL
H.	NULL
Fujiwara	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
mechanism	NULL
underlying	NULL
synergy	NULL
between	NULL
IL-12	NULL
and	NULL
IFN-y-inducing	NULL
factor	NULL
in	NULL
enhanced	NULL
production	NULL
of	NULL
IFN-y	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:2125	NULL
.	NULL

35	NULL
.	NULL

Sattler	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
A.	NULL
Durstin	NULL
,	NULL
D.	NULL
A.	NULL
Frank	NULL
,	NULL
K.	NULL
Okuda	NULL
,	NULL
K.	NULL
Kaushansky	NULL
,	NULL
R.	NULL
Salgia	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Griffin	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
thrombopoietin	NULL
receptor	NULL
c-MPL	NULL
activates	NULL
JAK2	NULL
and	NULL
TYK2	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Exp	NULL
.	NULL

Hematol	NULL
.	NULL

23:1040	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

Frank	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
L.	NULL
Varticovski	NULL
.	NULL

1996	NULL
.	NULL

BCR/abl	NULL
leads	NULL
to	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
Stat	NULL
proteins	NULL
,	NULL
and	NULL
shares	NULL
an	NULL
epitope	NULL
with	NULL
tyrosine	NULL
phosphorylated	NULL
Stats	NULL
.	NULL

Leukemia	NULL
10:1724	NULL
.	NULL

Gollob	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
C.	NULL
P.	NULL
Schnipper	NULL
,	NULL
E.	NULL
Orsini	NULL
,	NULL
E.	NULL
A.	NULL
Murphy	NULL
,	NULL
J.	NULL
F.	NULL
Daley	NULL
,	NULL
S.	NULL
B.	NULL
Lazo	NULL
,	NULL
D.	NULL
A.	NULL
Frank	NULL
,	NULL
D.	NULL
Neuberg	NULL
,	NULL
and	NULL
J.	NULL
Ritz	NULL
.	NULL

1998	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
novel	NULL
subset	NULL
of	NULL
CD8*	NULL
T	NULL
cells	NULL
that	NULL
expands	NULL
in	NULL
patients	NULL
receiving	NULL
interleukin-12	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

102	NULL
;	NULL
:561	NULL
.	NULL

Cui	NULL
,	NULL
J.	NULL
,	NULL
T.	NULL
Shin	NULL
,	NULL
T.	NULL
Kawano	NULL
,	NULL
H.	NULL
Sato	NULL
,	NULL
E.	NULL
Kondo	NULL
,	NULL
I.	NULL
Toura	NULL
,	NULL
Y.	NULL
Kaneko	NULL
,	NULL
H.	NULL
Koseki	NULL
,	NULL
M.	NULL
Kanno	NULL
,	NULL
and	NULL
M.	NULL
Taniguchi	NULL
.	NULL

1997	NULL
.	NULL

Requirement	NULL
for	NULL
Val4	NULL
NKT	NULL
cells	NULL
in	NULL
IL-12-mediated	NULL
rejection	NULL
of	NULL
tumors	NULL
.	NULL

Science	NULL
278:1623	NULL
.	NULL

Tough	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
P.	NULL
Borrow	NULL
,	NULL
and	NULL
J.	NULL
Sprent	NULL
.	NULL

1996	NULL
.	NULL

Induction	NULL
of	NULL
bystander	NULL
T	NULL
cell	NULL
proliferation	NULL
by	NULL
viruses	NULL
and	NULL
type	NULL
I	NULL
interferon	NULL
in	NULL
vivo	NULL
.	NULL

Science	NULL
272:1947	NULL
.	NULL

Raingeaud	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
Gupta	NULL
,	NULL
J.	NULL
Rogers	NULL
,	NULL
M.	NULL
Dickens	NULL
,	NULL
J.	NULL
Han	NULL
,	NULL
R.	NULL
Ulevitch	NULL
,	NULL
and	NULL
R.	NULL
Davis	NULL
.	NULL

1995	NULL
.	NULL

Pro-inflammatory	NULL
cytokines	NULL
and	NULL
environmental	NULL
stress	NULL
cause	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
activation	NULL
by	NULL
dual	NULL
phosphorylation	NULL
on	NULL
tyrosine	NULL
and	NULL
thre-onine	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:7420	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
J.-D.	NULL
Lee	NULL
,	NULL
Y.	NULL
Jiang	NULL
,	NULL
Z.	NULL
Li	NULL
,	NULL
L.	NULL
Feng	NULL
,	NULL
and	NULL
R.	NULL
Ulevitch	NULL
.	NULL

1996	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
a	NULL
novel	NULL
MAP	NULL
kinase	NULL
kinase	NULL
(	NULL
MKK6	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:2886	NULL
.	NULL

Raingeaud	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Whitmarsh	NULL
,	NULL
T.	NULL
Barrett	NULL
,	NULL
B.	NULL
Derijard	NULL
,	NULL
and	NULL
R.	NULL
Davis	NULL
.	NULL

1996	NULL
.	NULL

MKK3-and	NULL
MKK6-regulated	NULL
gene	NULL
expression	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1247	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

4481	NULL
Gupta	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
B.	NULL
Derijard	NULL
,	NULL
and	NULL
R.	NULL
Davis	NULL
.	NULL

1995	NULL
.	NULL

Transcription	NULL
factor	NULL
ATF-2	NULL
regulation	NULL
by	NULL
the	NULL
JNK	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Science	NULL
267:389	NULL
.	NULL

Hazzalin	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
A.	NULL
Cuenda	NULL
,	NULL
E.	NULL
Cano	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
and	NULL
L.	NULL
C.	NULL
Mahadevan	NULL
.	NULL

1997	NULL
.	NULL

Effects	NULL
of	NULL
the	NULL
inhibition	NULL
of	NULL
p38/RK	NULL
MAP	NULL
kinase	NULL
on	NULL
induction	NULL
of	NULL
five	NULL
fos	NULL
and	NULL
jun	NULL
genes	NULL
by	NULL
diverse	NULL
stimuli	NULL
.	NULL

Oncogene	NULL
15:2321	NULL
.	NULL

Rincon	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Enslen	NULL
,	NULL
J.	NULL
Raingeaud	NULL
,	NULL
M.	NULL
Recht	NULL
,	NULL
T.	NULL
Zapton	NULL
,	NULL
S.-S.	NULL
Su	NULL
,	NULL
L.	NULL
A.	NULL
Penix	NULL
,	NULL
R.	NULL
J.	NULL
Davis	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1998	NULL
.	NULL

Interferon-y	NULL
expression	NULL
by	NULL
Th1	NULL
effector	NULL
T	NULL
cells	NULL
mediated	NULL
by	NULL
the	NULL
p38	NULL
MAP	NULL
kinase	NULL
signaling	NULL
pathway	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

17:2817	NULL
.	NULL

Zhang	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Y.	NULL
Zhao	NULL
,	NULL
B.	NULL
T.	NULL
Chait	NULL
,	NULL
W.	NULL
W.	NULL
Lathem	NULL
,	NULL
M.	NULL
Ritzi	NULL
,	NULL
R.	NULL
Knippers	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Damnell	NULL
,	NULL
Jr.	NULL
1998	NULL
.	NULL

Ser'*	NULL
``	NULL
-dependent	NULL
recruitment	NULL
of	NULL
MCMS	NULL
by	NULL
Statla	NULL
in	NULL
IFN-y-induced	NULL
transcriptional	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

17:6963	NULL
.	NULL

Freshney	NULL
,	NULL
N.	NULL
,	NULL
L.	NULL
Rawlinson	NULL
,	NULL
F.	NULL
Guesdon	NULL
,	NULL
E.	NULL
Jones	NULL
,	NULL
S.	NULL
Cowley	NULL
,	NULL
J.	NULL
Hsuan	NULL
,	NULL
and	NULL
J.	NULL
Saklatvala	NULL
.	NULL

1994	NULL
.	NULL

Interleukin-1	NULL
activates	NULL
a	NULL
novel	NULL
protein	NULL
kinase	NULL
cascade	NULL
that	NULL
results	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
hsp27	NULL
.	NULL

Cell	NULL
78:1039	NULL
.	NULL

Rouse	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
S.	NULL
Trigon	NULL
,	NULL
M.	NULL
Morange	NULL
,	NULL
A.	NULL
Alonso-Llamazares	NULL
,	NULL
D.	NULL
Zamanillo	NULL
,	NULL
T.	NULL
Hunt	NULL
,	NULL
and	NULL
A.	NULL
Nebreda	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
novel	NULL
kinase	NULL
cascade	NULL
triggered	NULL
by	NULL
stress	NULL
and	NULL
heat	NULL
shock	NULL
that	NULL
stimulates	NULL
MAPKAP	NULL
kinase-2	NULL
and	NULL
phosphorylation	NULL
of	NULL
the	NULL
small	NULL
heat	NULL
shock	NULL
proteins	NULL
.	NULL

Cell	NULL
78:1024	NULL
.	NULL

Gonzalez	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
D.	NULL
L.	NULL
Raden	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
substrate	NULL
recognition	NULL
determinants	NULL
for	NULL
human	NULL
ERK1	NULL
and	NULL
ERK2	NULL
protein	NULL
kinases	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:22159	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

